CN114854702B - Herbicide tolerance protein, coding gene and application thereof - Google Patents
Herbicide tolerance protein, coding gene and application thereof Download PDFInfo
- Publication number
- CN114854702B CN114854702B CN202210330228.1A CN202210330228A CN114854702B CN 114854702 B CN114854702 B CN 114854702B CN 202210330228 A CN202210330228 A CN 202210330228A CN 114854702 B CN114854702 B CN 114854702B
- Authority
- CN
- China
- Prior art keywords
- plant
- protein
- gene
- herbicide
- hppd inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004009 herbicide Substances 0.000 title claims abstract description 237
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 192
- 230000002363 herbicidal effect Effects 0.000 title claims abstract description 191
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 115
- 239000003112 inhibitor Substances 0.000 claims abstract description 88
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 21
- 101100339555 Zymoseptoria tritici HPPD gene Proteins 0.000 claims abstract description 15
- 241000196324 Embryophyta Species 0.000 claims description 261
- 239000002773 nucleotide Substances 0.000 claims description 69
- 125000003729 nucleotide group Chemical group 0.000 claims description 69
- 230000014509 gene expression Effects 0.000 claims description 60
- 238000000034 method Methods 0.000 claims description 57
- IYMLUHWAJFXAQP-UHFFFAOYSA-N topramezone Chemical compound CC1=C(C(=O)C2=C(N(C)N=C2)O)C=CC(S(C)(=O)=O)=C1C1=NOCC1 IYMLUHWAJFXAQP-UHFFFAOYSA-N 0.000 claims description 38
- 244000062793 Sorghum vulgare Species 0.000 claims description 32
- 239000005562 Glyphosate Substances 0.000 claims description 24
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 claims description 24
- 229940097068 glyphosate Drugs 0.000 claims description 24
- KPUREKXXPHOJQT-UHFFFAOYSA-N mesotrione Chemical compound [O-][N+](=O)C1=CC(S(=O)(=O)C)=CC=C1C(=O)C1C(=O)CCCC1=O KPUREKXXPHOJQT-UHFFFAOYSA-N 0.000 claims description 24
- 239000005578 Mesotrione Substances 0.000 claims description 23
- 239000013598 vector Substances 0.000 claims description 22
- 240000008042 Zea mays Species 0.000 claims description 20
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 20
- 244000068988 Glycine max Species 0.000 claims description 18
- 240000007594 Oryza sativa Species 0.000 claims description 18
- 235000007164 Oryza sativa Nutrition 0.000 claims description 18
- 235000009566 rice Nutrition 0.000 claims description 18
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 17
- 244000105624 Arachis hypogaea Species 0.000 claims description 17
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 17
- 235000018262 Arachis monticola Nutrition 0.000 claims description 17
- 235000010469 Glycine max Nutrition 0.000 claims description 17
- 240000005979 Hordeum vulgare Species 0.000 claims description 17
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 17
- 235000020232 peanut Nutrition 0.000 claims description 17
- 244000075850 Avena orientalis Species 0.000 claims description 16
- 235000007319 Avena orientalis Nutrition 0.000 claims description 16
- 235000007558 Avena sp Nutrition 0.000 claims description 16
- 229920000742 Cotton Polymers 0.000 claims description 16
- 240000008067 Cucumis sativus Species 0.000 claims description 16
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 16
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 16
- 240000003768 Solanum lycopersicum Species 0.000 claims description 16
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 16
- 244000061456 Solanum tuberosum Species 0.000 claims description 16
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 16
- 241000209140 Triticum Species 0.000 claims description 16
- 235000021307 Triticum Nutrition 0.000 claims description 16
- 235000019713 millet Nutrition 0.000 claims description 16
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 15
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 15
- 240000000385 Brassica napus var. napus Species 0.000 claims description 15
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 15
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 15
- 241000219823 Medicago Species 0.000 claims description 15
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 15
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 15
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 14
- 241000335053 Beta vulgaris Species 0.000 claims description 14
- 235000010523 Cicer arietinum Nutrition 0.000 claims description 14
- 244000045195 Cicer arietinum Species 0.000 claims description 14
- 244000020551 Helianthus annuus Species 0.000 claims description 14
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 14
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 14
- 235000005822 corn Nutrition 0.000 claims description 14
- 241000743776 Brachypodium distachyon Species 0.000 claims description 11
- 208000027418 Wounds and injury Diseases 0.000 claims description 11
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 claims description 9
- 241000219195 Arabidopsis thaliana Species 0.000 claims description 9
- 230000006378 damage Effects 0.000 claims description 9
- 239000005561 Glufosinate Substances 0.000 claims description 8
- -1 diketene nitrile Chemical class 0.000 claims description 7
- 230000012010 growth Effects 0.000 claims description 7
- 230000001105 regulatory effect Effects 0.000 claims description 7
- ZTTKDUXKVPEXCG-UHFFFAOYSA-N 2-cyano-3-cyclopropyl-1-(2-mesyl-4-trifluoromethylphenyl)propan-1,3-dione Chemical compound CS(=O)(=O)C1=CC(C(F)(F)F)=CC=C1C(=O)C(C#N)C(=O)C1CC1 ZTTKDUXKVPEXCG-UHFFFAOYSA-N 0.000 claims description 6
- 108010020183 3-phosphoshikimate 1-carboxyvinyltransferase Proteins 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 6
- 230000002068 genetic effect Effects 0.000 claims description 6
- 208000014674 injury Diseases 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- 230000001276 controlling effect Effects 0.000 claims description 5
- 238000010362 genome editing Methods 0.000 claims description 5
- 238000003306 harvesting Methods 0.000 claims description 5
- 230000008635 plant growth Effects 0.000 claims description 5
- 108010000700 Acetolactate synthase Proteins 0.000 claims description 4
- 206010064571 Gene mutation Diseases 0.000 claims description 4
- 108020001991 Protoporphyrinogen Oxidase Proteins 0.000 claims description 4
- 238000011426 transformation method Methods 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- 102000005135 Protoporphyrinogen oxidase Human genes 0.000 claims description 3
- 108020002494 acetyltransferase Proteins 0.000 claims description 3
- 230000008654 plant damage Effects 0.000 claims description 3
- 108010016119 Alpha-Ketoglutarate-Dependent Dioxygenase FTO Proteins 0.000 claims description 2
- 102000000383 Alpha-Ketoglutarate-Dependent Dioxygenase FTO Human genes 0.000 claims description 2
- 108030006517 Glyphosate oxidoreductases Proteins 0.000 claims description 2
- 101000951943 Stenotrophomonas maltophilia Dicamba O-demethylase, oxygenase component Proteins 0.000 claims description 2
- 102000005421 acetyltransferase Human genes 0.000 claims description 2
- 108010039239 glyphosate N-acetyltransferase Proteins 0.000 claims description 2
- 244000299507 Gossypium hirsutum Species 0.000 claims 7
- 244000061176 Nicotiana tabacum Species 0.000 claims 7
- 241000743774 Brachypodium Species 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 abstract description 11
- 108010028143 Dioxygenases Proteins 0.000 abstract description 7
- 102000016680 Dioxygenases Human genes 0.000 abstract description 7
- 235000018102 proteins Nutrition 0.000 description 98
- 241000219194 Arabidopsis Species 0.000 description 45
- 239000013604 expression vector Substances 0.000 description 44
- 210000004027 cell Anatomy 0.000 description 38
- 102000040430 polynucleotide Human genes 0.000 description 36
- 108091033319 polynucleotide Proteins 0.000 description 36
- 239000002157 polynucleotide Substances 0.000 description 36
- 238000003259 recombinant expression Methods 0.000 description 34
- 230000000694 effects Effects 0.000 description 30
- 150000007523 nucleic acids Chemical class 0.000 description 29
- 102000039446 nucleic acids Human genes 0.000 description 26
- 108020004707 nucleic acids Proteins 0.000 description 26
- 230000009466 transformation Effects 0.000 description 21
- 102000004190 Enzymes Human genes 0.000 description 20
- 108090000790 Enzymes Proteins 0.000 description 20
- 230000002401 inhibitory effect Effects 0.000 description 20
- 239000000047 product Substances 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- IGMNYECMUMZDDF-UHFFFAOYSA-N homogentisic acid Chemical compound OC(=O)CC1=CC(O)=CC=C1O IGMNYECMUMZDDF-UHFFFAOYSA-N 0.000 description 14
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical class O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 14
- 230000009261 transgenic effect Effects 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 12
- 239000003623 enhancer Substances 0.000 description 11
- 229940024606 amino acid Drugs 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000003752 polymerase chain reaction Methods 0.000 description 10
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 241000219146 Gossypium Species 0.000 description 9
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 8
- 101150046173 HP1 gene Proteins 0.000 description 8
- 241000208125 Nicotiana Species 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 8
- 229960000268 spectinomycin Drugs 0.000 description 8
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- VOYADQIFGGIKAT-UHFFFAOYSA-N 1,3-dibutyl-4-hydroxy-2,6-dioxopyrimidine-5-carboximidamide Chemical compound CCCCn1c(O)c(C(N)=N)c(=O)n(CCCC)c1=O VOYADQIFGGIKAT-UHFFFAOYSA-N 0.000 description 7
- 241000589158 Agrobacterium Species 0.000 description 7
- 241000701489 Cauliflower mosaic virus Species 0.000 description 7
- 108091026890 Coding region Proteins 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- 230000002087 whitening effect Effects 0.000 description 7
- KKADPXVIOXHVKN-UHFFFAOYSA-N 4-hydroxyphenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=C(O)C=C1 KKADPXVIOXHVKN-UHFFFAOYSA-N 0.000 description 6
- 241000209510 Liliopsida Species 0.000 description 6
- 108010076504 Protein Sorting Signals Proteins 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 6
- 241001233957 eudicotyledons Species 0.000 description 6
- 238000009396 hybridization Methods 0.000 description 6
- 235000009973 maize Nutrition 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 230000008488 polyadenylation Effects 0.000 description 6
- 230000006798 recombination Effects 0.000 description 6
- 238000005215 recombination Methods 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000037430 deletion Effects 0.000 description 5
- 238000012217 deletion Methods 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 230000002255 enzymatic effect Effects 0.000 description 5
- 229930027917 kanamycin Natural products 0.000 description 5
- 229960000318 kanamycin Drugs 0.000 description 5
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 5
- 229930182823 kanamycin A Natural products 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 101150113864 pat gene Proteins 0.000 description 5
- 230000035939 shock Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000701484 Figwort mosaic virus Species 0.000 description 4
- 108091092195 Intron Proteins 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- 235000010582 Pisum sativum Nutrition 0.000 description 4
- 240000004713 Pisum sativum Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 108010055059 beta-Mannosidase Proteins 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 235000021466 carotenoid Nutrition 0.000 description 4
- 150000001747 carotenoids Chemical class 0.000 description 4
- 108010031100 chloroplast transit peptides Proteins 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 150000002545 isoxazoles Chemical class 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 4
- 229960001225 rifampicin Drugs 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 239000012137 tryptone Substances 0.000 description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 102100032487 Beta-mannosidase Human genes 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 244000025670 Eleusine indica Species 0.000 description 3
- 235000014716 Eleusine indica Nutrition 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 240000000111 Saccharum officinarum Species 0.000 description 3
- 235000007201 Saccharum officinarum Nutrition 0.000 description 3
- 108091081024 Start codon Proteins 0.000 description 3
- 230000009418 agronomic effect Effects 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000035784 germination Effects 0.000 description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- OYIKARCXOQLFHF-UHFFFAOYSA-N isoxaflutole Chemical compound CS(=O)(=O)C1=CC(C(F)(F)F)=CC=C1C(=O)C1=C(C2CC2)ON=C1 OYIKARCXOQLFHF-UHFFFAOYSA-N 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 108091027963 non-coding RNA Proteins 0.000 description 3
- 102000042567 non-coding RNA Human genes 0.000 description 3
- 108010058731 nopaline synthase Proteins 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 108010001545 phytoene dehydrogenase Proteins 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 230000014621 translational initiation Effects 0.000 description 3
- 239000010455 vermiculite Substances 0.000 description 3
- 229910052902 vermiculite Inorganic materials 0.000 description 3
- 235000019354 vermiculite Nutrition 0.000 description 3
- LUBJCRLGQSPQNN-UHFFFAOYSA-N 1-Phenylurea Chemical compound NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 102100028626 4-hydroxyphenylpyruvate dioxygenase Human genes 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241001515826 Cassava vein mosaic virus Species 0.000 description 2
- 241000233838 Commelina Species 0.000 description 2
- 239000005504 Dicamba Substances 0.000 description 2
- 235000001602 Digitaria X umfolozi Nutrition 0.000 description 2
- 235000017898 Digitaria ciliaris Nutrition 0.000 description 2
- 235000005476 Digitaria cruciata Nutrition 0.000 description 2
- 235000006830 Digitaria didactyla Nutrition 0.000 description 2
- 235000005804 Digitaria eriantha ssp. eriantha Nutrition 0.000 description 2
- 235000010823 Digitaria sanguinalis Nutrition 0.000 description 2
- 241000710188 Encephalomyocarditis virus Species 0.000 description 2
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000005571 Isoxaflutole Substances 0.000 description 2
- 241000723994 Maize dwarf mosaic virus Species 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 244000070788 Milium effusum Species 0.000 description 2
- 235000007199 Panicum miliaceum Nutrition 0.000 description 2
- 108010068204 Peptide Elongation Factors Proteins 0.000 description 2
- FKUYMLZIRPABFK-UHFFFAOYSA-N Plastoquinone 9 Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCC1=CC(=O)C(C)=C(C)C1=O FKUYMLZIRPABFK-UHFFFAOYSA-N 0.000 description 2
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
- 108020005091 Replication Origin Proteins 0.000 description 2
- 238000010459 TALEN Methods 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 241000723873 Tobacco mosaic virus Species 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 102000004243 Tubulin Human genes 0.000 description 2
- 108090000704 Tubulin Proteins 0.000 description 2
- 102000044159 Ubiquitin Human genes 0.000 description 2
- 108090000848 Ubiquitin Proteins 0.000 description 2
- 108010017070 Zinc Finger Nucleases Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- MXWJVTOOROXGIU-UHFFFAOYSA-N atrazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)C)=N1 MXWJVTOOROXGIU-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- IWEDIXLBFLAXBO-UHFFFAOYSA-N dicamba Chemical compound COC1=C(Cl)C=CC(Cl)=C1C(O)=O IWEDIXLBFLAXBO-UHFFFAOYSA-N 0.000 description 2
- 230000005059 dormancy Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 2
- 208000006278 hypochromic anemia Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 229940088649 isoxaflutole Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- FKUYMLZIRPABFK-IQSNHBBHSA-N plastoquinone-9 Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=CC(=O)C(C)=C(C)C1=O FKUYMLZIRPABFK-IQSNHBBHSA-N 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000009465 prokaryotic expression Effects 0.000 description 2
- DWSPRBSLSXQIEJ-UHFFFAOYSA-N pyrasulfotole Chemical compound CC1=NN(C)C(O)=C1C(=O)C1=CC=C(C(F)(F)F)C=C1S(C)(=O)=O DWSPRBSLSXQIEJ-UHFFFAOYSA-N 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- PQTBTIFWAXVEPB-UHFFFAOYSA-N sulcotrione Chemical compound ClC1=CC(S(=O)(=O)C)=CC=C1C(=O)C1C(=O)CCCC1=O PQTBTIFWAXVEPB-UHFFFAOYSA-N 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 108700026220 vif Genes Proteins 0.000 description 2
- GGKNTGJPGZQNID-UHFFFAOYSA-N (1-$l^{1}-oxidanyl-2,2,6,6-tetramethylpiperidin-4-yl)-trimethylazanium Chemical compound CC1(C)CC([N+](C)(C)C)CC(C)(C)N1[O] GGKNTGJPGZQNID-UHFFFAOYSA-N 0.000 description 1
- XUHGTGGPZFJRMF-UHFFFAOYSA-N 1,3-dihydropyrazole-2-carboxylic acid Chemical compound OC(=O)N1CC=CN1 XUHGTGGPZFJRMF-UHFFFAOYSA-N 0.000 description 1
- 101150072531 10 gene Proteins 0.000 description 1
- 102100027328 2-hydroxyacyl-CoA lyase 2 Human genes 0.000 description 1
- UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 1
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 1
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 description 1
- 102100039601 ARF GTPase-activating protein GIT1 Human genes 0.000 description 1
- 101710194905 ARF GTPase-activating protein GIT1 Proteins 0.000 description 1
- 241000219144 Abutilon Species 0.000 description 1
- 241000448435 Acalypha australis Species 0.000 description 1
- 240000002245 Acer pensylvanicum Species 0.000 description 1
- 235000006760 Acer pensylvanicum Nutrition 0.000 description 1
- 101710103719 Acetolactate synthase large subunit Proteins 0.000 description 1
- 101710182467 Acetolactate synthase large subunit IlvB1 Proteins 0.000 description 1
- 101710171176 Acetolactate synthase large subunit IlvG Proteins 0.000 description 1
- 101710176702 Acetolactate synthase small subunit Proteins 0.000 description 1
- 101710147947 Acetolactate synthase small subunit 1, chloroplastic Proteins 0.000 description 1
- 101710095712 Acetolactate synthase, mitochondrial Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 101900318283 Alfalfa mosaic virus Capsid protein Proteins 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000237956 Amaranthus retroflexus Species 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000218993 Begonia Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 239000005489 Bromoxynil Substances 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 101001033883 Cenchritis muricatus Protease inhibitor 2 Proteins 0.000 description 1
- 241000747028 Cestrum yellow leaf curling virus Species 0.000 description 1
- 241000219312 Chenopodium Species 0.000 description 1
- 240000006740 Cichorium endivia Species 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 241000701515 Commelina yellow mottle virus Species 0.000 description 1
- 241000518484 Cotton leaf curl virus Species 0.000 description 1
- 241000219112 Cucumis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 1
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 1
- 108010007218 Cytochromes b6 Proteins 0.000 description 1
- 108010075021 Cytochromes f Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 1
- 240000006497 Dianthus caryophyllus Species 0.000 description 1
- 101100125027 Dictyostelium discoideum mhsp70 gene Proteins 0.000 description 1
- 239000005947 Dimethoate Substances 0.000 description 1
- 101150048726 E9 gene Proteins 0.000 description 1
- 101150111720 EPSPS gene Proteins 0.000 description 1
- 244000058871 Echinochloa crus-galli Species 0.000 description 1
- 108091006149 Electron carriers Proteins 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- 235000002917 Fraxinus ornus Nutrition 0.000 description 1
- 101150104463 GOS2 gene Proteins 0.000 description 1
- 235000014820 Galium aparine Nutrition 0.000 description 1
- 206010071602 Genetic polymorphism Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 101150012639 HPPD gene Proteins 0.000 description 1
- 101150031823 HSP70 gene Proteins 0.000 description 1
- 101710081758 High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 101000985215 Homo sapiens 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 description 1
- 101000899240 Homo sapiens Endoplasmic reticulum chaperone BiP Proteins 0.000 description 1
- ZHLWCBHWYUISFY-UHFFFAOYSA-N Hydroxyphenylpyruvic acid Chemical compound OC(=O)C(=O)C(O)C1=CC=CC=C1 ZHLWCBHWYUISFY-UHFFFAOYSA-N 0.000 description 1
- 208000030036 Hypertelorism-preauricular sinus-punctual pits-deafness syndrome Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108010061833 Integrases Proteins 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 208000035719 Maculopathy Diseases 0.000 description 1
- 235000009053 Mirabilis jalapa Nutrition 0.000 description 1
- 244000022198 Mirabilis jalapa Species 0.000 description 1
- 101710202061 N-acetyltransferase Proteins 0.000 description 1
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 231100000674 Phytotoxicity Toxicity 0.000 description 1
- 241001144416 Picornavirales Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 108010089814 Plant Lectins Proteins 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 241000710078 Potyvirus Species 0.000 description 1
- 101710196435 Probable acetolactate synthase large subunit Proteins 0.000 description 1
- 101710181764 Probable acetolactate synthase small subunit Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100029028 Protoporphyrinogen oxidase Human genes 0.000 description 1
- 101710104000 Putative acetolactate synthase small subunit Proteins 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 244000082988 Secale cereale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 235000001155 Setaria leucopila Nutrition 0.000 description 1
- 241000820163 Setaria leucopila Species 0.000 description 1
- 235000010086 Setaria viridis var. viridis Nutrition 0.000 description 1
- 108010052160 Site-specific recombinase Proteins 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002594 Solanum nigrum Nutrition 0.000 description 1
- 240000002307 Solanum ptychanthum Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108010043934 Sucrose synthase Proteins 0.000 description 1
- 239000005618 Sulcotrione Substances 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 239000005620 Tembotrione Substances 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102000016540 Tyrosine aminotransferases Human genes 0.000 description 1
- 108010042606 Tyrosine transaminase Proteins 0.000 description 1
- 108020004417 Untranslated RNA Proteins 0.000 description 1
- 102000039634 Untranslated RNA Human genes 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 241001148683 Zostera marina Species 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 description 1
- 229940051880 analgesics and antipyretics pyrazolones Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- BEHLMOQXOSLGHN-UHFFFAOYSA-N benzenamine sulfate Chemical compound OS(=O)(=O)NC1=CC=CC=C1 BEHLMOQXOSLGHN-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229940027138 cambia Drugs 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000002230 centromere Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000003733 chicria Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- KXZOIWWTXOCYKR-UHFFFAOYSA-M diclofenac potassium Chemical compound [K+].[O-]C(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl KXZOIWWTXOCYKR-UHFFFAOYSA-M 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 101150052825 dnaK gene Proteins 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 244000304962 green bristle grass Species 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 101150031530 hpn gene Proteins 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000012994 industrial processing Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000010198 maturation time Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000000442 meristematic effect Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229910001453 nickel ion Inorganic materials 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 238000012794 pre-harvesting Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 101150078341 rop gene Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000004550 soluble concentrate Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 229910052567 struvite Inorganic materials 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- IUQAXCIUEPFPSF-UHFFFAOYSA-N tembotrione Chemical compound ClC1=C(COCC(F)(F)F)C(S(=O)(=O)C)=CC=C1C(=O)C1C(=O)CCCC1=O IUQAXCIUEPFPSF-UHFFFAOYSA-N 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- YWBFPKPWMSWWEA-UHFFFAOYSA-O triazolopyrimidine Chemical compound BrC1=CC=CC(C=2N=C3N=CN[N+]3=C(NCC=3C=CN=CC=3)C=2)=C1 YWBFPKPWMSWWEA-UHFFFAOYSA-O 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
- C12Y113/11—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of two atoms of oxygen (1.13.11)
- C12Y113/11027—4-Hydroxyphenylpyruvate dioxygenase (1.13.11.27)
Abstract
The invention relates to a herbicide tolerance protein, a coding gene and application thereof, wherein the protein comprises the following components: (a) Has an amino acid sequence shown as SEQ ID NO. 6 or SEQ ID NO. 9; (b) The protein derived from (a) wherein the amino acid sequence in (a) is substituted and/or deleted and/or added with one or more amino acids and has hydroxyphenylpyruvate dioxygenase. The herbicide tolerance protein can endow plants with tolerance to HPPD inhibitor herbicides, and has wide application prospects in plants.
Description
The application is a divisional application of Chinese patent application 202010194585.0, the application name is: herbicide tolerance protein, coding gene and application thereof, and application date: 3 months and 19 days 2020.
Technical Field
The invention relates to herbicide tolerance protein, a coding gene and application thereof, in particular to protein with tolerance to HPPD inhibitor herbicide, a coding gene and application thereof.
Background
Hydroxyphenylpyruvate dioxygenase (hydroxyphenylpyruvate dioxygenase, abbreviated as HPPD) is an enzyme which catalyzes the reaction of the degradation product of tyrosine, p-hydroxyphenylpyruvate (hydroxyphenylpyruvic acid, abbreviated as HPP), to homogentisate/homogentisate (homogentisate, abbreviated as HG), a precursor of tocopherols and plastoquinone (plastoquinone, abbreviated as PQ) in plants, in the presence of iron ions (Fe 2+) and oxygen. Tocopherol has the function of a membrane-associated antioxidant; PQ is not only an electron carrier between PS II and the cytochrome b6/f complex, but is also an essential cofactor for phytoene desaturase in carotenoid biosynthesis.
Herbicides that act by inhibiting HPPD are mainly three chemical families of triones, isoxazoles and pyrazolones. In plants, they block the biosynthesis of PQ from tyrosine by inhibiting HPPD, resulting in PQ depletion and carotenoid deficiency. The above-described HPPD-inhibiting herbicides are plant phloem-mobile bleaches that can cause new meristematic tissues and leaves exposed to light to appear white, whereas carotenoids are essential for photoprotection, and in the absence of carotenoids, uv radiation and reactive oxygen intermediates can disrupt chlorophyll synthesis and function, leading to inhibition of plant growth and even death.
The method for providing a HPPD inhibitor herbicide tolerant plant consists essentially of: 1) HPPD is overexpressed to produce large amounts of HPPD in plants, which, despite the presence of the HPPD inhibitor herbicide, are sufficiently active with the HPPD inhibitor herbicide to have sufficient functional enzyme available for use. 2) The target HPPD is mutated to a functional HPPD that is less sensitive to herbicides or active metabolites thereof, but which retains the property of being converted to HG. Regarding the class of mutant HPPDs, while a given mutant HPPD may provide a useful level of tolerance to some HPPD inhibitor herbicides, the same mutant HPPD may not be sufficient to provide a commercial level of tolerance to a different, more desirable HPPD inhibitor herbicide; for example, HPPD inhibitor herbicides can vary in the range of weeds they control, their cost of manufacture, and their environmental friendliness. Thus, there is a need for new methods and/or compositions for conferring HPPD inhibitor herbicide tolerance to different crops and crop varieties.
Disclosure of Invention
The object of the present invention is to provide a novel protein which not only has HPPD enzyme activity but also makes plants transformed with the protein-encoding gene tolerant to HPPD inhibitor herbicides, a gene encoding the same and uses thereof.
To achieve the above object, the present invention provides a protein comprising:
(a) Has an amino acid sequence shown as SEQ ID NO. 6 or SEQ ID NO. 9;
(b) And (b) a protein derived from (a) and having hydroxyphenylpyruvate dioxygenase activity, wherein the amino acid sequence in (a) is substituted and/or deleted and/or added with one or more amino acids.
To achieve the above object, the present invention provides a gene comprising:
(a) A nucleotide sequence encoding the protein of claim 1; or (b)
(B) A nucleotide sequence which hybridizes under stringent conditions to the nucleotide sequence defined in (a) and which encodes a protein having hydroxyphenylpyruvate dioxygenase activity; or (b)
(C) Has the nucleotide sequence shown as SEQ ID NO. 7, SEQ ID NO. 8, SEQ ID NO. 10 or SEQ ID NO. 11.
The stringent conditions may be hybridization in 6 XSSC (sodium citrate), 0.5% SDS (sodium dodecyl sulfate) solution at 65℃and then washing the membrane 1 time with 2 XSSC, 0.1% SDS and 1 XSSC, 0.1% SDS, respectively.
To achieve the above object, the present invention also provides an expression cassette comprising the gene under the control of operably linked regulatory sequences.
To achieve the above object, the present invention also provides a recombinant vector comprising the gene or the expression cassette
To achieve the above object, the present invention also provides a method for expanding the range of herbicide tolerance of plants, comprising: the protein or the protein encoded by the expression cassette is expressed in a plant together with at least one second herbicide tolerance protein different from the protein or the protein encoded by the expression cassette.
Further, the second herbicide tolerance protein is 5-enolpyruvylshikimate-3-phosphate synthase, glyphosate oxidoreductase, glyphosate-N-acetyltransferase, glyphosate decarboxylase, glufosinate acetyltransferase, alpha ketoglutarate-dependent dioxygenase, dicamba monooxygenase, acetolactate synthase, cytochrome-like proteins, and/or protoporphyrinogen oxidase.
To achieve the above object, the present invention also provides a method of selecting a transformed plant cell, comprising: transforming a plurality of plant cells with said gene or said expression cassette and culturing said cells at a concentration of HPPD inhibitor herbicide that allows growth of transformed cells expressing said gene or said expression cassette while killing or inhibiting growth of untransformed cells;
Preferably, the plant comprises a monocot and a dicot; more preferably, the plant is oat, wheat, barley, millet, corn, sorghum, brachypodium distachyon, rice, tobacco, sunflower, alfalfa, soybean, chickpea, peanut, beet, cucumber, cotton, canola, potato, tomato, or arabidopsis;
Preferably, the HPPD inhibitor herbicide comprises a pyrazolone HPPD inhibitor herbicide, a trione HPPD inhibitor herbicide, and/or an isoxazole HPPD inhibitor herbicide; more preferably, the HPPD inhibitor herbicide is topramezone, mesotrione, and/or diketopyroil.
To achieve the above object, the present invention also provides a method of controlling weeds, comprising: applying an effective dose of an HPPD inhibitor herbicide to a field in which a plant of interest is grown, the plant of interest comprising the gene or the expression cassette or the recombinant vector;
Preferably, the plant of interest includes monocotyledonous plants and dicotyledonous plants; more preferably, the plant of interest is oat, wheat, barley, millet, corn, sorghum, brachypodium distachyon, rice, tobacco, sunflower, alfalfa, soybean, chickpea, peanut, beet, cucumber, cotton, canola, potato, tomato, or arabidopsis; further preferably, the plant of interest is a glyphosate tolerant plant and the weed is a glyphosate resistant weed;
Preferably, the HPPD inhibitor herbicide comprises a pyrazolone HPPD inhibitor herbicide, a trione HPPD inhibitor herbicide, and/or an isoxazole HPPD inhibitor herbicide; more preferably, the HPPD inhibitor herbicide is topramezone, mesotrione, and/or diketopyroil.
To achieve the above object, the present invention also provides a method for protecting a plant from damage caused by or conferring HPPD inhibitor herbicide tolerance to a plant, comprising: introducing said gene or said expression cassette or said recombinant vector into a plant such that the introduced plant produces an amount of herbicide tolerance protein sufficient to protect it from HPPD inhibitor herbicides;
Preferably, the plant comprises a monocot and a dicot; more preferably, the plant is oat, wheat, barley, millet, corn, sorghum, brachypodium distachyon, rice, tobacco, sunflower, alfalfa, soybean, chickpea, peanut, beet, cucumber, cotton, canola, potato, tomato, or arabidopsis;
Preferably, the HPPD inhibitor herbicide comprises a pyrazolone HPPD inhibitor herbicide, a trione HPPD inhibitor herbicide, and/or an isoxazole HPPD inhibitor herbicide; more preferably, the HPPD inhibitor herbicide is topramezone, mesotrione, and/or diketopyroil.
To achieve the above object, the present invention also provides a method for producing a plant tolerant to an HPPD inhibitor herbicide, comprising introducing the gene into the genome of the plant;
Preferably, the method of introducing comprises a genetic transformation method, a genome editing method or a gene mutation method;
In particular, the method of producing a HPPD inhibitor herbicide tolerant plant comprises: generating an HPPD inhibitor herbicide tolerant plant by selfing or crossing a parent plant and/or a second plant, said parent plant and/or second plant comprising said gene or said expression cassette, said HPPD inhibitor herbicide tolerant plant inherits said gene or said expression cassette from said parent plant and/or second plant;
Preferably, the plant comprises a monocot and a dicot; more preferably, the plant is oat, wheat, barley, millet, corn, sorghum, brachypodium distachyon, rice, tobacco, sunflower, alfalfa, soybean, chickpea, peanut, beet, cucumber, cotton, canola, potato, tomato, or arabidopsis;
Preferably, the HPPD inhibitor herbicide comprises a pyrazolone HPPD inhibitor herbicide, a trione HPPD inhibitor herbicide, and/or an isoxazole HPPD inhibitor herbicide; more preferably, the HPPD inhibitor herbicide is topramezone, mesotrione, and/or diketopyroil.
To achieve the above object, the present invention also provides a method of culturing a plant tolerant to an HPPD inhibitor herbicide, comprising:
planting at least one plant propagule comprising the gene or the expression cassette in the genome of the plant propagule;
growing the plant propagules into plants;
applying an effective dose of an HPPD inhibitor herbicide to a plant growth environment comprising at least said plant, harvesting a plant having reduced plant damage and/or increased plant yield as compared to other plants not having said gene or said expression cassette;
Preferably, the plant comprises a monocot and a dicot; more preferably, the plant is oat, wheat, barley, millet, corn, sorghum, brachypodium distachyon, rice, tobacco, sunflower, alfalfa, soybean, chickpea, peanut, beet, cucumber, cotton, canola, potato, tomato, or arabidopsis;
Preferably, the HPPD inhibitor herbicide comprises a pyrazolone HPPD inhibitor herbicide, a trione HPPD inhibitor herbicide, and/or an isoxazole HPPD inhibitor herbicide; more preferably, the HPPD inhibitor herbicide is topramezone, mesotrione, and/or diketopyroil.
The present invention also provides a method of obtaining a processed agricultural product comprising treating a harvest of HPPD inhibitor herbicide tolerant plants obtained by the method to obtain a processed agricultural product.
To achieve the above object, the present invention also provides a planting system for controlling weed growth, comprising applying an HPPD inhibitor herbicide and a plant growth environment in which at least one plant of interest is present, said plant of interest comprising said gene or said expression cassette;
Preferably, the plant of interest includes monocotyledonous plants and dicotyledonous plants; more preferably, the plant of interest is oat, wheat, barley, millet, corn, sorghum, brachypodium distachyon, rice, tobacco, sunflower, alfalfa, soybean, chickpea, peanut, beet, cucumber, cotton, canola, potato, tomato, or arabidopsis; further preferably, the plant of interest is a glyphosate tolerant plant and the weed is a glyphosate resistant weed;
Preferably, the HPPD inhibitor herbicide comprises a pyrazolone HPPD inhibitor herbicide, a trione HPPD inhibitor herbicide, and/or an isoxazole HPPD inhibitor herbicide; more preferably, the HPPD inhibitor herbicide is topramezone, mesotrione, and/or diketopyroil.
To achieve the above object, the present invention also provides the use of the protein in conferring HPPD inhibitor herbicides on plants;
Preferably, the plant comprises a monocot and a dicot; more preferably, the plant is oat, wheat, barley, millet, corn, sorghum, brachypodium distachyon, rice, tobacco, sunflower, alfalfa, soybean, chickpea, peanut, beet, cucumber, cotton, canola, potato, tomato, or arabidopsis;
Preferably, the HPPD inhibitor herbicide comprises a pyrazolone HPPD inhibitor herbicide, a trione HPPD inhibitor herbicide, and/or an isoxazole HPPD inhibitor herbicide; more preferably, the HPPD inhibitor herbicide is topramezone, mesotrione, and/or diketopyroil.
The articles "a" and "an" as used herein mean one or more than one (i.e., at least one). For example, "an element" means one or more elements. Furthermore, the terms "comprises," "comprising," or any other variation thereof, such as "includes" or "including," are to be understood to mean including one of the elements, integers or steps, or a group of elements, integers or steps, but not excluding any other elements, integers or steps, or groups of elements, integers or steps.
In the present invention, the term "hydroxyphenylpyruvate dioxygenase (HPPD)" is synonymous with "4-hydroxyphenylpyruvate dioxygenase (4-HPPD)" and "p-hydroxyphenylpyruvate dioxygenase (p-HPPD)".
The term "HPPD inhibiting herbicide" is synonymous with "HPPD herbicide" and refers to herbicides that inhibit HPPD, either directly or indirectly, which are bleaches, and whose primary site of action is HPPD. The most commercially available HPPD inhibiting herbicides belong to one of three chemical families: (1) Triones, for example, sulcotrione (i.e. 2- [ 2-chloro-4- (methylsulfonyl) benzoyl ] -1, 3-cyclohexanedione), mesotrione (i.e. 2- [4- (methylsulfonyl) -2-nitrobenzoyl ] -1, 3-cyclohexanedione), tembotrione (i.e. 2- [ 2-chloro-4- (methylsulfonyl) -3- [ (2, 2-trifluoroethoxy) methyl ] benzoyl ] -1, 3-cyclohexanedione); (2) Isoxazoles (in plants, isoxazoles HPPD herbicides are rapidly converted to biologically active diketopyrrolopyrroles (diketonitrile, DKN) to exert an inhibitory effect on HPPD, so that the diketopyrrolopyrroles are active forms of isoxazoles HPPD-inhibiting herbicides), for example isoxaflutole (isoxaflutole) (i.e. 5-cyclopropyl-4-isoxazolyl [2- (methylsulfonyl) -4- (trifluoromethyl) phenyl ] methanone); (3) Pyrazolones (pyrazolinate) such as topramezone (i.e., [3- (4, 5-dihydro-3-isoxazolyl) -2-methyl-4- (methylsulfonyl) phenyl ] (5-hydroxy-1-methylpyrazol-4-yl) methanone), sulfonyloxazomet (pyrasulfotole) (5-hydroxy-1, 3-dimethylpyrazol-4-yl (2-methylsulfonyl-4-trifluoromethylphenyl) methanone).
The topramezone, also called topramezone, refers to [3- (4, 5-dihydro-3-isoxazolyl) -2-methyl-4- (methylsulfonyl) phenyl ] (5-hydroxy-1-methylpyrazol-4-yl) methanone, which is a white crystalline solid. The systemic conduction HPPD herbicide belongs to pyrazolone (pyrazolinate) post-emergence stem and leaf treatment, and the common dosage form is 30% suspending agent. Topramezone commercial preparations such as bract guard can control grassy and broadleaf weeds, and 5.6-6.7g of the preparation is used for each mu, and weeds which can be effectively controlled, including but not limited to crabgrass (herba aristolochiae), barnyard grass, goosegrass, wild millet, green bristlegrass (Guzi), chenopodium, polygonum, green hemp, abutilon, wild amaranth, purslane, siberian cocklebur and black nightshade. The atrazine-containing herbicide has remarkable synergistic effect after the atrazine is added, has excellent control effect on the weeds, can also have good control effect on malignant broadleaf weeds such as spiny grass (herba Cephalanoploris), endive, acalypha australis and dayflower (orchid), and can particularly effectively control bristlegrass, crabgrass, goosefoot and wild millet with poor control effect on mesotrione.
The effective dose of the topramezone disclosed by the invention is 25-100g ai/ha, including 50-100g ai/ha, 60-90g ai/ha or 75-85g ai/ha.
In the present invention, the term "resistance" is heritable and allows plants to grow and reproduce with herbicide treatment of a given plant in general herbicide-effective manner. As recognized by those skilled in the art, even if a given plant is subjected to some degree of injury, such as little necrosis, solubilization, chlorosis, or other injury, but at least not significantly affected in yield, the plant may still be considered "resistant", i.e., the given plant has an increased ability to resist various degrees of injury induced by the herbicide, while generally resulting in injury to wild type plants of the same genotype at the same herbicide dose. The term "resistance" or "tolerance" is used herein more broadly than the term "resistance" and includes "resistance".
The term "conferring" in the present invention refers to providing a plant with a characteristic or trait, such as herbicide tolerance and/or other desired trait.
The term "heterologous" in the present invention means from another source. In the context of DNA, "heterologous" refers to any foreign "non-self" DNA, including DNA from another plant of the same species. For example, in the present invention, the soybean HPPD gene, which is still considered to be "heterologous" DNA, can be expressed in soybean plants using transgenic methods.
The term "nucleic acid" in the present invention includes reference to deoxyribonucleotide or ribonucleotide polymers in either single-or double-stranded form, and unless otherwise limited, includes known analogues having the basic properties of natural nucleotides (e.g., peptide nucleic acids) in that they hybridize to single-stranded nucleic acids in a manner similar to naturally occurring nucleotides.
In the present invention, when the term "encoding" or "encoding" is used in the context of a particular nucleic acid, it means that the nucleic acid contains the necessary information to direct the translation of the nucleotide sequence into a particular protein. The information used to encode the protein is specified by the use of codons. The nucleic acid encoding the protein may comprise an untranslated sequence (e.g., an intron) within the translated region of the nucleic acid, or may lack such an inserted untranslated sequence (e.g., in a cDNA).
The herbicide tolerance proteins of the invention have HPPD enzyme activity and confer tolerance in plants to certain classes of HPPD-inhibiting herbicides. The DNA sequences encoding the herbicide tolerance proteins of the invention are useful for providing plants, crops, plant cells and seeds of the invention that provide enhanced tolerance to one or more HPPD herbicides.
Genes encoding the herbicide tolerance proteins of the invention are useful for producing plants that are tolerant to HPPD inhibiting herbicides. The herbicide tolerance gene is particularly suitable for expression in plants in order to confer herbicide tolerance to the plants.
The terms "polypeptide", "peptide" and "protein" are used interchangeably herein to refer to a polymer of amino acid residues. These terms apply to polymers of amino acid residues, one or more of which are an artificial chemical analogue of a corresponding naturally occurring amino acid, as well as naturally occurring amino acid polymers. The proteins of the invention may be produced from a nucleic acid of the disclosure or by using standard molecular biology techniques. For example, a truncated protein of the invention may be produced by expressing a recombinant nucleic acid of the invention in a suitable host cell, or alternatively by combining ex vivo methods (e.g., protease digestion and purification).
The invention also provides nucleic acid molecules comprising polynucleotide sequences encoding herbicide tolerance proteins that have HPPD enzyme activity and confer tolerance to certain classes of HPPD-inhibiting herbicides in plants. In general, the invention includes any polynucleotide sequence encoding any herbicide tolerance protein described herein, as well as any polynucleotide sequence encoding a herbicide tolerance protein having one or more conservative amino acid substitutions relative to the herbicide tolerance proteins described herein. It is well known to those skilled in the art to provide functionally similar amino acid conservative substitutions, and the following five groups each comprise amino acids that are conservative substitutions for one another: aliphatic: glycine (G), alanine (a), valine (V), leucine (L), isoleucine (I); aromatic: phenylalanine (F), tyrosine (Y), tryptophan (W); sulfur-containing: methionine (M), cysteine (C); alkaline: arginine (I), lysine (K), histidine (H); acidic: aspartic acid (D), glutamic acid (E), asparagine (N), glutamine (Q).
Thus, sequences that have HPPD inhibiting herbicide tolerance activity and hybridize under stringent conditions to genes encoding herbicide tolerance proteins of the invention are included in the invention. Illustratively, these sequences have at least about 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or more sequence homology to the sequences of the invention SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 7, SEQ ID NO. 8, SEQ ID NO. 10, SEQ ID NO. 11.
Any conventional nucleic acid hybridization or amplification method can be used to identify the presence of the herbicide tolerance genes of the present invention. The nucleic acid molecule or fragment thereof is capable of specifically hybridizing to other nucleic acid molecules under certain conditions. In the present invention, two nucleic acid molecules can be said to specifically hybridize to each other if they form an antiparallel double-stranded nucleic acid structure. Two nucleic acid molecules are said to be "complements" of one nucleic acid molecule if they exhibit complete complementarity. In the present invention, a nucleic acid molecule is said to exhibit "complete complementarity" when each nucleotide of the two molecules is complementary to a corresponding nucleotide of the other nucleic acid molecule. Two nucleic acid molecules are said to be "minimally complementary" if they are capable of hybridizing to each other with sufficient stability such that they anneal and bind to each other under at least conventional "low stringency" conditions. Similarly, two nucleic acid molecules are said to have "complementarity" if they are capable of hybridizing to each other with sufficient stability such that they anneal and bind to each other under conventional "highly stringent" conditions. Deviations from complete complementarity are permissible provided that such deviations do not completely prevent the formation of double-stranded structures by the two molecules. In order to enable a nucleic acid molecule to act as a primer or probe, it is only necessary to ensure sufficient complementarity in sequence to allow the formation of a stable double-stranded structure at the particular solvent and salt concentration employed.
In the present invention, a substantially homologous sequence is a nucleic acid molecule that specifically hybridizes to the complementary strand of a matching nucleic acid molecule under highly stringent conditions. Suitable stringent conditions for promoting DNA hybridization, for example, treatment with 6.0 XSSC/sodium citrate (SSC) at about 45℃followed by washing with 2.0 XSSC at 50℃are well known to those skilled in the art. For example, the salt concentration in the washing step may be selected from about 2.0 XSSC at low stringency conditions, about 0.2 XSSC at 50℃to high stringency conditions, about 50 ℃. In addition, the temperature conditions in the washing step may be raised from about 22 ℃ at room temperature under low stringency conditions to about 65 ℃ under high stringency conditions. The temperature conditions and salt concentration may both be varied, or one may remain unchanged while the other variable is varied. Preferably, the stringent conditions of the present invention may be specific hybridization with the herbicide tolerance gene of the present invention in 6 XSSC, 0.5% SDS solution at 65℃and then washing the membrane 1 time with 2 XSSC, 0.1% SDS and 1 XSSC, 0.1% SDS.
In the present invention, the term "hybridization" or "specific hybridization" refers to a molecule that can bind, double-stranded or hybridize only to a specific nucleotide sequence under stringent conditions when the sequence is present in a complex mixture (e.g., total cell) DNA or RNA.
Due to the redundancy of the genetic code, a variety of different DNA sequences may encode the same amino acid sequence. The generation of these alternative DNA sequences encoding the same or substantially the same protein is within the skill level of those skilled in the art. These different DNA sequences are included within the scope of the present invention. The term "substantially identical" sequence refers to a sequence having amino acid substitutions, deletions, additions or insertions without substantially affecting the herbicide tolerance activity, and also includes fragments that retain the herbicide tolerance activity.
The term "functional activity" or "activity" in the present invention refers to the ability of the protein/enzyme of use of the invention (alone or in combination with other proteins) to degrade or attenuate the activity of a herbicide. Plants producing a protein of the invention preferably produce an "effective amount" of the protein such that when the plant is treated with the herbicide, the protein is expressed at a level sufficient to render the plant wholly or partially tolerant to the herbicide (typically in amounts unless specifically indicated). The herbicide may be used in amounts, in normal field amounts and concentrations that would normally kill the target plant. Preferably, the plant cells and plants of the invention are protected from growth inhibition or damage caused by herbicide treatment. The transformed plants and plant cells of the invention preferably have tolerance to HPPD inhibiting herbicides, i.e. the transformed plants and plant cells are capable of growing in the presence of an effective amount of an HPPD inhibiting herbicide.
Genes and proteins described herein include not only the specific exemplified sequences, but also portions and/or fragments (including internal and/or terminal deletions as compared to the full-length protein), variants, mutants, variant proteins, substitutions (proteins with alternative amino acids), chimeras and fusion proteins that preserve the HPPD-inhibiting herbicide tolerance activity characteristics of the specific exemplified proteins.
The term "variant" according to the invention means a substantially similar sequence. For polynucleotides, a variant includes a deletion and/or addition of one or more nucleotides at one or more internal sites within the reference polynucleotide and/or a substitution of one or more nucleotides at one or more sites in the herbicide tolerance gene. The term "reference polynucleotide or polypeptide" in the present invention correspondingly includes herbicide tolerance nucleotide sequences or amino acid sequences. The term "native polynucleotide or polypeptide" in the present invention correspondingly includes naturally occurring nucleotide sequences or amino acid sequences. For polynucleotides, conservative variants include nucleotide sequences encoding one of these herbicide tolerance proteins of the invention (due to the degeneracy of the genetic code). Such naturally occurring allelic variants can be identified using well known molecular biological techniques, for example using the Polymerase Chain Reaction (PCR) and hybridization techniques outlined below. Variant polynucleotides also include synthetically derived polynucleotides, such as sequences produced by using site-directed mutagenesis but which nevertheless encode a herbicide tolerance protein of the invention. Typically, variants of a particular polynucleotide of the invention will have at least about 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or more sequence homology to the particular polynucleotide, the homology being determined by sequence alignment procedures and parameters.
By "variant protein" in the present invention is meant a protein derived from a reference protein by deletion or addition of one or more amino acids at one or more internal sites in the herbicide tolerance protein and/or substitution of one or more amino acids at one or more sites in the herbicide tolerance protein. Variant proteins encompassed by the present invention are biologically active, i.e. they continue to have the desired activity of the herbicide tolerance protein, i.e. still have the described HPPD enzyme activity and/or herbicide tolerance. Such variants may arise, for example, from genetic polymorphisms or from manual manipulation. A biologically active variant of a herbicide tolerance protein of the invention will have at least about 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or more sequence homology to all of the amino acid sequences of the herbicide tolerance protein as determined by sequence alignment procedures and parameters. A biologically active variant of a protein of the invention may differ from a protein with as few as 1-15 amino acid residues, as few as 1-10 (e.g., 6-10), as few as 5 (e.g., 4, 3, 2, or even 1) amino acid residues.
Methods for alignment are well known in the art and can be accomplished using mathematical algorithms such as the MYERS AND MILLER (1988) CABIOS 4:11-17 algorithm; a local alignment algorithm of Smith et al (1981) adv.appl.math.2:482; NEED EMAN AND Wunsch (1970) J.mol.biol.48:443-453 global alignment algorithm; and KARLIN AND Altschul (1990) Proc.Natl. Acad.Sci.USA 872264, as modified in KARLIN AND Altschul (1993) Proc.Natl. Acad.Sci.USA 90:5873-5877. Computer implementations of these mathematical algorithms may be utilized for sequence comparison to determine sequence homology, such implementations including, but not limited to: CLUSTAL in the PC/Gene program (available from Intelligenetics, mountain View, california); ALLGN programs (version 2.0) and GAP, BESTFIT, BLAST, FASTA and TFASTA (available from accelrys inc.,9685Scranton Road,San Diego,California,USA) in GCG Wisconsin Genetics Software Package version 10.
In certain embodiments, amino acids encoding herbicide tolerance proteins of the invention or variants thereof that retain HPPD enzymatic activity can be stacked with any combination of polynucleotide sequences of interest to produce plants having a desired trait. The term "trait" refers to a phenotype derived from a particular sequence or group of sequences. For example, a polynucleotide encoding an amino acid of the herbicide tolerance protein or variant that retains HPPD enzymatic activity may be superimposed with any other polynucleotide encoding a polypeptide that confers a desired trait, including, but not limited to: resistance to diseases, insects, and herbicides, tolerance to heat and drought, reduced crop maturation time, improved industrial processing (e.g., for converting starch or biomass to fermentable sugars), and improved agronomic quality (e.g., high oil content and high protein content).
The benefits of combinations of two or more modes of action in improving the controlled weed spectrum and/or naturally more tolerant or resistant weed species can also be extended to the creation of chemicals in crops that are resistant to herbicides other than HPPD tolerant crops by artificial (transgenic or non-transgenic) action, as is well known to those skilled in the art. In fact, the following resistant traits may be stacked singly or in multiple combinations to provide effective control or prevent weed succession from developing resistance to herbicides: glyphosate resistance (e.g., resistant plants or bacteria EPSPS, GOX, GAT), glufosinate resistance (e.g., PAT, bar), acetolactate synthase (ALS) inhibitory herbicide resistance (e.g., imidazolinone, sulfonylurea, triazolopyrimidine, sulfoaniline, pyrimidothiobenzoic acid and other chemical resistance genes such as AHAS, csrl, surA, etc.), phenoxy auxin herbicide resistance (e.g., aryloxyalkanoate dioxygenase-AAD), dicamba herbicide resistance (e.g., dicamba monooxygenase-DMO), bromoxynil resistance (e.g., bxn), resistance to Phytoene Desaturase (PDS) inhibitors, resistance to system ii inhibitory herbicides (e.g., psba), resistance to system i inhibitory herbicides, resistance to protoporphyrinogen oxidase ix (PPO) inhibitory herbicides (e.g., PPO-1), resistance to phenylurea herbicides (e.g., CYP76B 1), dimethoate degrading enzymes, etc.
Glyphosate is widely used because it controls a very broad spectrum of broadleaf and grass weed species. However, repeated use of glyphosate in glyphosate tolerant crops and non-crop applications has (and will continue to) select for species or glyphosate resistant biotypes that will shift weeds to naturally more tolerant. Most herbicide resistance management strategies suggest the use of an effective amount of a tank-mixed herbicide partner as a method of delaying the emergence of resistant weeds, which provides control of the same species, but with a different mode of action. Superimposing the herbicide tolerance genes of the invention with glyphosate tolerance traits (and/or other herbicide tolerance traits) can achieve control of glyphosate resistant weed species (broadleaf weed species controlled by one or more pyrazolone herbicides) in glyphosate tolerant crops by allowing selective use of glyphosate and pyrazolone herbicides (e.g., topramezone) on the same crop. The application of these herbicides can be simultaneous in a tank mix containing two or more herbicides of different modes of action, separate use of a single herbicide composition in successive uses (e.g. pre-planting, pre-emergence or post-emergence) with intervals ranging from 2 hours to 3 months, or alternatively any combination of numbers of herbicides representing applicable each class of compound can be used at any time (from 7 months in the crop to harvest (or pre-harvest interval for a single herbicide, shortest).
It is important to have flexibility in controlling broadleaf weeds, i.e., time of use, individual herbicide usage, and the ability to control refractory or resistant weeds. The range of glyphosate application in crops superimposed with the glyphosate resistance gene/herbicide tolerance gene of the invention can range from 250 to 2500g ae/ha; pyrazolone herbicide(s) may be present in an amount of from 25 to 500g ai/ha. The optimal combination of times for these applications depends on the particular conditions, species and circumstances.
Herbicide formulations (e.g., ester, acid or salt formulations or soluble concentrates, emulsifying concentrates or soluble liquids) and tank-mix additives (e.g., adjuvants or compatibilizers) can significantly affect weed control for a given herbicide or combination of one or more herbicides. Any chemical combination of any of the foregoing herbicides is within the scope of the present invention.
In addition, genes encoding the herbicide tolerance proteins of the invention can be superimposed with one or more other input (e.g., insect resistance, fungal resistance, stress tolerance, etc.) or output (e.g., increased yield, improved oil mass, increased fiber quality, etc.) traits, alone or in combination with other herbicide tolerance crop characteristics. Thus, the present invention can be used to provide a complete agronomic solution to flexibly and economically control any number of agronomic pests and to improve crop quality.
The combination of these stacks may be produced by any method including, but not limited to: crossbred plants or genetic transformation by conventional or top crossing methods. If these sequences are superimposed by genetic transformation of these plants, the polynucleotide sequences of interest may be combined at any time and in any order. For example, transgenic plants comprising one or more desired traits can be used as targets for introducing additional traits by subsequent transformation. These traits can be introduced simultaneously with the polynucleotide of interest provided by any combination of expression cassettes in a co-transformation scheme. For example, if two sequences are to be introduced, the two sequences may be contained in separate expression cassettes (trans) or in the same expression cassette (cis). Expression of these sequences may be driven by the same promoter or by different promoters. In some cases, it may be desirable to introduce an expression cassette that inhibits the expression of the polynucleotide of interest. This can be combined with any combination of other suppression or overexpression cassettes to produce the desired trait combination in the plant. It is further recognized that polynucleotide sequences may be stacked at a desired genomic location using a site-specific recombination system.
The gene encoding the herbicide tolerance protein has higher tolerance to pyrazolone herbicides, and is an important basis for herbicide tolerance crops and the possibility of selecting marker characteristics.
The term "expression cassette" in the present invention refers to a nucleic acid molecule capable of directing expression of a particular nucleotide sequence in an appropriate host cell, including a promoter operably linked to the nucleotide sequence of interest (i.e., a polynucleotide encoding a herbicide tolerance protein or variant that retains HPPD enzyme activity, either alone or in combination with one or more additional nucleic acid molecules encoding polypeptides conferring a desired trait), which nucleotide sequence of interest is operably linked to a termination signal. The coding region typically encodes a protein of interest, but may also encode a functional RNA of interest, such as antisense RNA or an untranslated RNA in sense or antisense orientation. The expression cassette comprising the nucleotide sequence of interest may be chimeric, meaning that at least one of its components is heterologous with respect to at least one of its other components. The expression cassette may also be a naturally occurring expression cassette, but must be obtained in recombinant form useful for heterologous expression. Typically, however, the expression cassette is heterologous to the host, i.e., the particular DNA sequence of the expression cassette does not naturally occur in the host cell and must have been introduced into a new host cell by a transformation event. Expression of the nucleotide sequence in the expression cassette may be under the control of a constitutive or inducible promoter that initiates transcription only when the host cell is exposed to some particular external stimulus. In addition, the promoter is specific for a particular tissue or organ or stage of development.
The present invention encompasses the transformation of plants with an expression cassette capable of expressing a polynucleotide of interest (i.e., a polynucleotide encoding a herbicide tolerance protein or variant thereof that retains HPPD enzymatic activity, either alone or in combination with one or more additional nucleic acid molecules encoding polypeptides conferring a desired trait). The expression cassette includes a transcription and translation initiation region (i.e., promoter) and a polynucleotide open reading frame in the 5'-3' direction of transcription. The expression cassette may optionally include transcriptional and translational termination regions (i.e., termination regions) that function in the plant. In some embodiments, the expression cassette includes a selectable marker gene to allow selection of stable transformants. The expression constructs of the invention may also include a leader sequence and/or a sequence that allows for inducible expression of the polynucleotide of interest.
The regulatory sequences of the expression cassette are operably linked to the polynucleotide of interest. The regulatory sequences of the present invention include, but are not limited to, promoters, transit peptides, terminators, enhancers, leader sequences, introns, and other regulatory sequences operably linked to a herbicide tolerance gene encoding the herbicide tolerance protein.
The promoter is an expressible promoter in a plant, and the expression promoter in the plant refers to a promoter which ensures that a coding sequence connected with the promoter is expressed in a plant cell. The promoter expressible in the plant may be a constitutive promoter. Examples of promoters that direct constitutive expression in plants include, but are not limited to, 35S promoters derived from cauliflower mosaic virus, maize Ubi promoter, promoters of rice GOS2 gene, and the like. Alternatively, the promoter that is expressible in a plant may be a tissue-specific promoter, i.e. the promoter directs higher expression of the coding sequence in some tissues of the plant, such as in green tissues, than in other tissues of the plant (as may be determined by conventional RNA assays), such as the PEP carboxylase promoter. Alternatively, the promoter expressible in the plant may be a wound-inducible promoter. A wound-inducible promoter or a promoter that directs the pattern of wound-induced expression refers to a promoter that significantly increases expression of a coding sequence under the control of the promoter when the plant is subjected to a wound caused by mechanical or insect feeding, as compared to normal growth conditions. Examples of wound-inducible promoters include, but are not limited to, promoters of the protease inhibitor genes (pinI and pinII) and the maize protease inhibitor gene (MPI) of potato and tomato.
The transit peptide (also known as a secretion signal sequence or targeting sequence) is directed to direct the transgene product to a specific organelle or cellular compartment, and may be heterologous to the receptor protein, for example, targeting to the chloroplast using a sequence encoding a chloroplast transit peptide, or to the endoplasmic reticulum using a 'KDEL' retention sequence, or to the vacuole using CTPP of the barley plant lectin gene.
Such leader sequences include, but are not limited to, picornaviral leader sequences, such as EMCV leader sequences (encephalomyocarditis virus 5' non-coding region); potyvirus leader sequences, such as MDMV (maize dwarf mosaic virus) leader sequences; human immunoglobulin heavy chain binding proteins (bips); a non-translated leader sequence of alfalfa mosaic virus coat protein mRNA (AMV RNA 4); tobacco Mosaic Virus (TMV) leader sequence.
Such enhancers include, but are not limited to, the cauliflower mosaic virus (CaMV) enhancer, the Figwort Mosaic Virus (FMV) enhancer, the carnation weathered ring virus (CERV) enhancer, the cassava vein mosaic virus (CsVMV) enhancer, the Mirabilis jalapa mosaic virus (MMV) enhancer, the night yellow leaf curl virus (CmYLCV) enhancer, the Multan cotton leaf curl virus (CLCuMV), the dayflower maculopathy virus (CoYMV), and the peanut chlorosis line mosaic virus (PCLSV) enhancer.
For monocot applications, the introns include, but are not limited to, the maize hsp70 intron, the maize ubiquitin intron, adh intron 1, the sucrose synthase intron, or the rice Act1 intron. For dicot applications, the introns include, but are not limited to, the CAT-1 intron, the pKANNIBAL intron, the PIV2 intron, and the "superubiquitin" intron.
The terminator may be a suitable polyadenylation signal sequence for functioning in plants, including, but not limited to, a polyadenylation signal sequence derived from the Agrobacterium (Agrobacterium tumefaciens) nopaline synthase (NOS) gene, a polyadenylation signal sequence derived from the protease inhibitor II (pin II) gene, a polyadenylation signal sequence derived from the pea ssRUBISCO E9 gene, and a polyadenylation signal sequence derived from the alpha-tubulin (alpha-tubulin) gene.
"Operably linked" as used herein refers to a linkage of nucleic acid sequences such that one sequence provides the desired function for the linked sequences. In the present invention, the term "operably linked" may be used to link a promoter to a sequence of interest such that transcription of the sequence of interest is controlled and regulated by the promoter. "operably linked" when a sequence of interest encodes a protein and it is desired to obtain expression of the protein means: the promoter is linked to the sequence in such a way that the resulting transcript is efficiently translated. If the linkage of the promoter to the coding sequence is a transcript fusion and expression of the encoded protein is desired, the linkage is made such that the first translation initiation codon in the resulting transcript is the initiation codon of the coding sequence. Alternatively, if the linkage of the promoter to the coding sequence is a translational fusion and expression of the encoded protein is desired, the linkage is made such that the first translation initiation codon contained in the 5' untranslated sequence is linked to the promoter and the linkage is such that the resulting translational product is in frame with the translational open reading frame encoding the desired protein. Nucleic acid sequences that can be "operably linked" include, but are not limited to: sequences that provide gene expression functions (i.e., gene expression elements such as promoters, 5 'untranslated regions, introns, protein coding regions, 3' untranslated regions, polyadenylation sites and/or transcription terminators), sequences that provide DNA transfer and/or integration functions (i.e., T-DNA border sequences, site-specific recombinase recognition sites, integrase recognition sites), sequences that provide selective functions (i.e., antibiotic resistance markers, biosynthetic genes), sequences that provide scorable marker functions, sequences that assist sequence manipulation in vitro or in vivo (i.e., polylinker sequences, site-specific recombination sequences), and sequences that provide replication functions (i.e., bacterial origins of replication, autonomous replication sequences, centromere sequences).
The genome of a plant, plant tissue or plant cell as used herein refers to any genetic material within a plant, plant tissue or plant cell and includes the nuclear and plastid and mitochondrial genomes.
In the present invention, the term "plant part" or "plant tissue" includes plant cells, plant protoplasts, plant cell tissue cultures from which plants can be regenerated, plant calli, plant clusters, and plant cells that are intact in parts of plants or plants such as embryos, pollen, ovules, seeds, leaves, flowers, branches, fruits, cores, ears, cobs, husks, stems, roots, root tips, anthers, and the like.
The herbicide tolerance proteins of the present invention can be used in a variety of plants, including but not limited to alfalfa, beans, broccoli, cabbage, carrot, celery, cotton, cucumber, eggplant, lettuce, melon, pea, pepper, zucchini, radish, canola, spinach, soybean, pumpkin, tomato, arabidopsis, peanut, or watermelon; preferably, the dicotyledonous plant is cucumber, soybean, arabidopsis, tobacco, cotton, peanut or canola. Such monocotyledonous plants include, but are not limited to, maize, rice, sorghum, wheat, barley, rye, millet, sugarcane, oat, or turf grass; preferably, the monocotyledonous plant is maize, rice, sorghum, wheat, barley, millet, sugarcane or oat.
In the present invention, the term "plant transformation" refers to cloning a herbicide resistant or tolerant polynucleotide into an expression system, either alone or in combination with one or more additional nucleic acid molecules encoding polypeptides conferring a desired trait, that is, into a plant cell. The receptor and expression cassette of the invention may be introduced into plant cells in a variety of well known ways. In the context of polynucleotides, the term "introducing" (e.g., a nucleotide construct of interest) is intended to mean providing a polynucleotide to the plant in such a way that the polynucleotide gains access to or is achieved within a plant cell. Where more than one polynucleotide is to be introduced, these polynucleotides may be assembled as part of a single nucleotide construct, or as separate nucleotide constructs, and may be located on the same or different transformation vectors. Thus, or as part of a breeding program, such as in a plant, the polynucleotides may be introduced into a host cell of interest in a single transformation event, in separate transformation events. The methods of the invention do not depend on a particular method for introducing one or more polynucleotides into a plant, but merely obtaining access or implementation of the polynucleotide or polynucleotides to the interior of at least one cell of the plant. Methods known in the art for introducing one or more polynucleotides into a plant include, but are not limited to, transient transformation methods, stable transformation methods, virus-mediated methods, or genome editing techniques.
The term "stable transformation" refers to the introduction of a foreign gene into the genome of a plant and the stable integration into the genome of the plant and any successive generations thereof, resulting in stable inheritance of the foreign gene.
The term "transient transformation" refers to the introduction of a nucleic acid molecule or protein into a plant cell that performs a function but does not integrate into the plant genome, resulting in the inability of the exogenous gene to be stably inherited.
The term "genome editing technology" refers to a genome modification technology capable of performing accurate manipulation of a genome sequence, realizing manipulation of site-directed mutation, insertion, deletion, and the like of genes. Currently, genome editing techniques mainly include HE (homing endonuclease ), ZFN (zinc-finger nuclease), TALEN (transcription activator-like effector nuclease ), CRISPR (Clustered regulatory interspaced short palindromic repeat, clustered regularly interspaced short palindromic repeats).
Numerous transformation vectors available for plant transformation are known to those of skill in the art, and genes relevant to the present invention may be used in combination with any of the above-described vectors. The choice of vector will depend on the preferred transformation technique and the target species used for transformation. For certain target species, different antibiotic or herbicide selection markers may be preferred. Selection markers conventionally used in transformation include the nptl gene conferring resistance to kanamycin and related antibiotics or related herbicides (this gene was published by bevan et al, nature science, volume 304, pages 184-187, 1983), the herbicide glufosinate (also known as glufosinate; see the pat and bar genes of white et al published in 1990 on page 18 of Nucl. AcidsRes, volume 18 of 1062, spencer et al published in 1990 on pages 79-631 of Theor. Appl. Genet, and U.S. Pat. Nos. 5561236 and 5276268), the hpn gene conferring resistance to the antibiotic hygromycin (Blochinger & DIGGELMANN, mol. Cell biol.4: 2929-2931) and the dnfr gene conferring resistance to methotrexate (Bourouis et al, 1983 on EMBO J. Volume 2 of 1099-1104), the EPSPS gene conferring resistance to glyphosate (U.S. Pat. No. 4940935 and 5188642), the N-acetyltransferase gene of Glyphosate (GAT) also conferring resistance to glyphosate (Castle et al on page 304, manna number 1-1154 of science, and the mannase patent applications No. 3 of mannase, and the mannase genes described in U.S. Pat. No. 5,518 and the mannase patent publication No. 5767378-4225 are provided.
Methods for regenerating plants are also well known in the art. For example, ti plasmid vectors have been utilized for delivery of exogenous DNA, as well as direct DNA uptake, liposomes, electroporation, microinjection, and microprojectiles.
The planting system described herein refers to a combination of plants, any herbicide tolerance that it displays, and/or herbicide treatments that are available at different stages of plant development, resulting in high yielding and/or reduced wounding plants.
In the present invention, the weeds refer to plants which compete with cultivated plants of interest in a plant growing environment.
The terms "control" and/or "control" according to the present invention mean that at least an effective dose of the pyrazolone herbicide is applied directly (e.g., by spraying) into the plant growing environment to minimize weed development and/or stop growth. At the same time, the cultivated plants of interest should be morphologically normal and can be cultivated under conventional methods for consumption and/or production of the product; preferably, there is reduced plant damage and/or increased plant yield compared to a non-transgenic wild type plant. Such plants with reduced damage include, but are not limited to, improved stalk resistance, and/or increased grain weight, among others. The "control" and/or "control" effect of the herbicide tolerance protein on weeds can be independent and is not attenuated and/or lost by the presence of other "control" and/or "control" weed species. In particular, any tissue of a transgenic plant (containing a gene encoding a herbicide tolerance protein) is present and/or produced simultaneously and/or asynchronously, said herbicide tolerance protein and/or another substance that can control weeds, the presence of which does not affect nor cause the "control" and/or "control" effect of said herbicide tolerance protein on weeds to be achieved entirely and/or partially by said another substance, independently of said herbicide tolerance protein.
"Plant propagules" as used herein include, but are not limited to, plant sexual propagules and plant asexual propagules. Such plant propagules include, but are not limited to, plant seeds; the plant vegetative propagation body refers to a vegetative organ or a special tissue of a plant body, which can produce a new plant under ex vivo conditions; the vegetative organ or a particular tissue includes, but is not limited to, roots, stems and leaves, such as: plants using roots as vegetative propagation bodies include strawberries, sweet potatoes and the like; plants with stems as vegetative propagation material include sugarcane, potato (tuber) and the like; plants with leaves as vegetative propagation material include aloe and begonia etc.
The present invention can confer new herbicide resistance traits to plants and no adverse effect on phenotype, including yield, is observed. Plants of the invention are tolerant to levels as generally found in 2×,3×, or 4× of at least one herbicide tested. These improvements in tolerance levels are within the scope of the present invention. For example, a number of techniques known in the art may be predictably optimized and further developed to increase expression of a given gene.
The invention provides herbicide tolerance protein, a coding gene and application thereof, and the herbicide tolerance protein has the following advantages:
1. the herbicide tolerance proteins of the invention can confer tolerance to HPPD inhibitor herbicides on plants, at least 1-fold field concentration of topramezone.
2. The herbicide tolerance protein has wide application prospect in plants.
The technical scheme of the invention is further described in detail through the drawings and the embodiments.
Drawings
FIG. 1 is a schematic diagram of the structure of a prokaryotic recombinant expression vector DBN11765 containing the HP1 nucleotide sequence;
FIG. 2 is a graph showing the effect of the enzyme activity of the herbicide tolerance protein HP1 under different concentration gradients of HPPD inhibitor herbicides (topramezone, mesotrione or diketopyronitrile);
FIG. 3 is a graph showing the effect of the enzyme activity of the herbicide tolerance protein HP1-1 on HPPD inhibitor herbicides (topramezone, mesotrione or diketophenolide) at different concentration gradients;
FIG. 4 is a graph showing the effect of the enzyme activity of the herbicide tolerance protein HP1-2 on HPPD inhibitor herbicides (topramezone, mesotrione or diketophenolide) at different concentration gradients;
FIG. 5 is a schematic diagram of the structure of an Arabidopsis recombinant expression vector DBN11770 containing the HP1M nucleotide sequence;
FIG. 6 is a schematic diagram showing the structure of a control recombinant expression vector DBN11770N of the present invention.
Detailed Description
The herbicide tolerance protein, the coding gene and the technical scheme of the application are further described by specific examples.
First example, mutation and screening of HP1 Gene
1. Synthesis of HP1 Gene
The nucleotide sequence of the HP1 gene is synthesized as shown in SEQ ID NO. 2 in the sequence table, and the encoded HP1 protein is shown in SEQ ID NO. 1 in the sequence table. The HP1M nucleotide sequence encoding the amino acid sequence corresponding to HP1 is obtained according to the Arabidopsis preference codon, as shown in SEQ ID NO:3 of the sequence Listing.
2. Construction of HP1 Gene mutation library
After amplifying the above synthesized HP1 gene by PCR, cloning the amplified product onto the vector pUC118 according to the procedure described in the Takara product pUC118 vector (Takara, CAT: 3318), and introducing the ligated product into E.coli DH 5. Alpha. As a template, and error-prone PCR was performed using forward and reverse primers to mutate the HP1 gene due to random base mismatches.
The primer and error-prone PCR reaction system is as follows:
forward primer: 5'-cccaagcttgatggccgccgattccgaaaatc-3' as shown in SEQ ID NO. 4 of the sequence Listing (HindIII cleavage site underlined);
reverse primer: 5'-cgcggatcctcaggcatcgaccgtcacaacg-3' as shown in SEQ ID NO:5 of the sequence Listing (underlined as BamHI cleavage site);
the error-prone PCR reaction system (total volume 50. Mu.L) was:
The concentration of the plasmid DNA template is 1-10 ng/. Mu.L, the concentration of the forward primer is 10. Mu.M, and the concentration of the reverse primer is 10. Mu.M.
The error-prone PCR reaction conditions were:
And (3) carrying out agarose gel electrophoresis on the error-prone PCR product by 7g/L, cutting and recovering the error-prone PCR product, carrying out double enzyme digestion on the error-prone PCR product after the cutting and recovering and a pUC118 vector by using HindIII and BamHI, purifying the enzyme-digested product, carrying out enzyme linkage by using T4-DNA ligase, and then converting the enzyme-digested product into E.coli DH5 alpha sensitive to topramezone to construct an HP1 gene random mutation library.
3. Screening of HP1 Gene mutation library
The transformation products in the mutation library were inoculated into a 48-well plate containing 300. Mu.M of topramezone in 2mL LB liquid medium (ampicillin 100mg/L, tyrosine 800 mg/L) and shake-cultured in a shaking table at a constant temperature of 37℃and 180 rpm. And (3) observing the growth condition of the strain, and when the strain grows to OD 0.4-0.6, adding 1mM IPTG into the LB liquid medium, continuing culturing, and observing the color change of the medium.
Because of the presence of tyrosine aminotransferase in E.coli, which catalyzes the production of p-Hydroxyphenylpyruvate (HPP), HPP can be utilized as a substrate for HPPD, and the product HG after HPPD catalytic reaction can spontaneously oxidize and polymerize to produce purplish red purplish melanin, but HPPD inhibitors can inhibit HPPD enzyme activity and thus inhibit color production. Thus, the above mutant library can be subjected to high throughput screening according to whether or not reddish brown color is produced in LB liquid medium, and E.coli DH 5. Alpha. Still producing reddish brown color on the above medium containing 300. Mu.M topramezone can be isolated to obtain a resistance gene.
4. Obtaining mutated resistance genes
Sequencing results show that two HP1 mutant resistance genes are obtained and are respectively named as HP1-1 and HP1-2, wherein the 475 th site of the HP1-1 nucleotide sequence is mutated from the original A to G, so that the 159 th site of the amino acid sequence is mutated from the original threonine to alanine; the mutation of the HP1-2 nucleotide sequences 772 and 773 from the original CA to AT results in the mutation of the amino acid sequence 258 from the original glutamine to methionine.
The amino acid sequence of the herbicide tolerance protein HP1-1 is shown as SEQ ID NO. 6 in a sequence table, and the nucleotide sequence of the HP1-1 encoding the amino acid sequence corresponding to the herbicide tolerance protein HP1-1 is shown as SEQ ID NO. 7 in the sequence table; the HP1-1M nucleotide sequence of the amino acid sequence corresponding to the herbicide tolerance protein HP1-1 is obtained according to the Arabidopsis preference codon, and is shown as SEQ ID NO. 8 in a sequence table.
The amino acid sequence of the herbicide tolerance protein HP1-2 is shown as SEQ ID NO 9 in a sequence table, and the nucleotide sequence of the HP1-2, which codes for the amino acid sequence corresponding to the herbicide tolerance protein HP1-2, is shown as SEQ ID NO 10 in the sequence table; the HP1-2M nucleotide sequence encoding the amino acid sequence corresponding to the herbicide tolerance protein HP1-2 is obtained according to the Arabidopsis preference codon, and is shown as SEQ ID NO. 11 in the sequence table.
Second example, tolerance Effect detection of herbicide tolerance proteins HP1-1 and HP1-2 against HPPD inhibitor herbicides
1. Synthesis of nucleotide sequences of HP1, HP1-1 and HP1-2
The 5 'and 3' ends of the HP1 nucleotide sequence (SEQ ID NO: 2), the HP-1 nucleotide sequence (SEQ ID NO: 7) and the HP1-2 nucleotide sequence (SEQ ID NO: 10) are respectively connected with a universal joint primer 1:
5' -terminal universal adaptor primer 1:5'-taagaaggagatatacatatg-3', shown as SEQ ID NO. 12 in the sequence Listing;
3' -terminal universal adaptor primer 1:5'-gtggtggtggtggtgctcgag-3' as shown in SEQ ID NO:13 of the sequence Listing.
2. Construction of prokaryotic recombinant expression vector and obtaining of recombinant Strain
The prokaryotic expression vector DBNBC-01 is subjected to double digestion reaction by using restriction endonucleases Nde I and Xho I, so that the prokaryotic expression vector is linearized, the digestion product is purified to obtain a linearized DBNBC-01 expression vector skeleton (vector skeleton: pET-29a (+), the HP1 nucleotide sequence connected with the universal joint primer 1 and the linearized DBNBC-01 expression vector skeleton are subjected to recombination reaction, the operation steps are carried out according to the instruction of Takara company In-Fusion seamless ligation product kit (Clontech, CA, USA, CAT 121416) to construct a recombinant expression vector DBN11765, the vector structure of which is shown In figure 1 (F1 Ori: replication origin of F1; kan: kanamycin resistance gene; ori: replication origin; rop: rop gene; encoding ROP protein; T7 protter: T7 RNA polymerase promoter; HP1: HP1 nucleotide sequence (SEQ ID NO: 2)), 6xHis: affinity tag, 6 continuous His, and a lacmap 3R 7 RNA polymerase promoter; lacmap operator I, lacter lacmap 3, lacmap operator I, lacter lacmap 7 RNA polymerase promoter, lacmap gene, lacr gene 3. Lacc 7 RNA polymerase promoter.
The recombinant expression vector DBN11765 is used for transforming competent cells of the escherichia coli BL21 (DE 3) by a heat shock method, and the heat shock conditions are as follows: 50. Mu.L of E.coli BL21 (DE 3) competent cells, 10. Mu.L of plasmid DNA (recombinant expression vector DBN 11765), 42℃in a water bath for 30s; shake culturing at 37deg.C for 1 hr (shaking table at 100 rpm); then, the white colonies were picked up and cultured overnight at 37℃in LB liquid medium (tryptone 10g/L, yeast extract 5g/L, naCl g/L, kanamycin 50mg/L, pH adjusted to 7.5 with NaOH) on the LB solid plate containing 50mg/L Kanamycin (KANAMYCIN) at 37℃for 12 hours. Extracting the plasmid by an alkaline method. Sequencing and identifying the extracted plasmid, and the result shows that the nucleotide sequence of the recombinant expression vector DBN11765 between Nde I and Xho I sites is the nucleotide sequence shown as SEQ ID NO. 2 in the sequence table, and the recombinant strain BL21 (HP 1) is preserved for standby.
According to the method for constructing the recombinant expression vector DBN11765, the HP1-1 nucleotide sequence and the HP1-2 nucleotide sequence which are connected with the universal joint primer 1 are respectively subjected to recombination reaction with the linearized DBNBC-01 expression vector skeleton, so that the recombinant expression vectors DBN11774 and DBN11775 are sequentially obtained. The recombinant expression vectors DBN11774 and DBN11775 are respectively transformed into competent cells of escherichia coli BL21 (DE 3) by a heat shock method, plasmids are extracted by an alkaline method, sequencing verification is carried out on the extracted plasmids, and the result shows that the nucleotide sequences in the recombinant expression vectors DBN11774 and DBN11775 respectively contain a nucleotide sequence shown as SEQ ID NO. 7 and a nucleotide sequence shown as SEQ ID NO.10 in a sequence table, namely, the HP1-1 nucleotide sequence and the HP1-2 nucleotide sequence are correctly inserted. The resulting recombinant strains BL21 (HP 1-1) and BL21 (HP 1-2) were stored for use.
3. Expression and purification of herbicide tolerance proteins in E.coli
The recombinant strains BL21 (HP 1), BL21 (HP 1-1) and BL21 (HP 1-2) were individually inoculated in 100mL of LB medium (tryptone 10g/L, yeast extract 5g/L, naCl g/L, ampicillin 100mg/L, pH was adjusted to 7.5 with NaOH) and cultured to a concentration of OD 600nm =0.6-0.8, IPTG at a concentration of 0.4mM was added, and induction was performed at 16℃for 12 hours. The cells were collected, resuspended in 15mL of PBS buffer (50 mM, pH 7.4), sonicated (X0-900D ultrasonic processor ultrasonic processor,30%intensity) for 10min, centrifuged, the supernatant collected, and the obtained herbicide-resistant proteins were purified by nickel ion affinity chromatography, and the purified results were detected by SDS-PAGE protein electrophoresis, with a band size consistent with that predicted by theory.
4. Determination of resistance of HP1, HP1-1 and HP1-2 to HPPD inhibitor herbicides
Enzymatic reaction system (1 mL): comprising 25. Mu.g of the reaction enzyme (the herbicide tolerance protein HP1, HP1-1 or HP1-2 obtained by the above purification), 0.2mM HPP substrate, 1mM Fe 2+, 1mM ascorbic acid, different concentration gradients (concentrations of 0. Mu.M, 5. Mu.M, 10. Mu.M, 20. Mu.M, 30. Mu.M, 40. Mu.M and 50. Mu.M respectively) and the buffer system was 50mM PBS buffer (pH 7.4) and reacted at 30℃for 20min in a water bath, each reaction starting with the addition of the reaction enzyme, and the boiling water bath was terminated for 5 min.
Centrifugally filtering the terminated enzyme reaction system, and taking 20 mu L of filtrate for High Performance Liquid Chromatography (HPLC) analysis, wherein the HPLC conditions are as follows: the mobile phase was acetonitrile in water (30:70, V/V) to which was added 0.1% trifluoroacetic acid. C18 reversed phase chromatographic column (5 μm,250 mm. Times.4.6 mm), column temperature of 40deg.C, VWD-3100 single wavelength ultraviolet detector, detection wavelength of 292nm, sample injection amount of 20 μl, and flow rate of 1.0mL/min. According to HPLC analysis, the peak time of the enzymatic reaction product is consistent with that of a homogentisate standard sample, and the reaction system without adding enzyme does not generate homogentisate. The resistance of HP1, HP1-1 and HP1-2 was tested according to the different concentrations of HPPD inhibitor herbicide (topramezone, mesotrione or diketophenolide) added to the system, specifically: the IC 50 of the HPPD inhibitor herbicide on HP1, HP1-1 and HP1-2 (concentration of HPPD inhibitor herbicide when the enzymatic activity catalytic reaction was inhibited by 50%) was calculated by measuring the amount of product homogentisate by HPLC, based on the relative enzymatic activity when the HPPD inhibitor herbicide was not added as 100%. One enzyme activity unit is defined as: the amount of enzyme required to produce 1. Mu. Mol of homogentisate in 1min at pH 7.4 and 30 ℃. The results of the experiments are shown in FIGS. 2-4 (graphs of the enzyme activity of the herbicide tolerance proteins HP1, HP1-1 and HP1-2 under different concentration gradients of HPPD inhibitor herbicides (topramezone, mesotrione or diketopyronitrile)) and the IC 50 values of topramezone, mesotrione and diketopyronitrile for HP1, HP1-1 and HP1-2 were calculated by nonlinear fitting using Prism 6.0 software and the results are shown in Table 1.
TABLE 1 half inhibitory concentration of HPPD inhibitor herbicides topramezone, mesotrione and diketopyronitrile on HP1, HP1-1 and HP1-2
The results in table 1 show that: herbicide tolerance proteins HP1, HP1-1 and HP1-2 are all tolerant to HPPD inhibitor herbicides (topramezone, mesotrione and diketophenolide) to varying degrees; the purified herbicide tolerance proteins HP1-1 and HP1-2 are more resistant to HPPD inhibitor herbicides than the herbicide tolerance protein HP 1.
Third example, acquisition and verification of transgenic Arabidopsis plants
1. Construction of recombinant expression vectors of Arabidopsis thaliana containing HP1, HP1-1 or HP1-2 genes, respectively
The 5 'and 3' ends of the HP1M nucleotide sequence (SEQ ID NO: 3) described in the above first example 1, the HP1-1M nucleotide sequence (SEQ ID NO: 8) and the HP1-2M nucleotide sequence (SEQ ID NO: 11) described in the above first example 4 were ligated to the universal adaptor primer 2, respectively:
5' Universal adaptor primer 2:5'-agtttttctgattaacagactagt-3', shown as SEQ ID NO. 14 in the sequence Listing;
3' -terminal universal adaptor primer 2:5'-caaatgtttgaacgatcggcgcgcc-3' as shown in SEQ ID NO. 15 of the sequence Listing.
Carrying out double digestion reaction on a plant expression vector DBNBC-02 by utilizing restriction endonucleases SpeI and Asc I, thereby linearizing the plant expression vector, purifying digestion products to obtain a linearized DBNBC-02 expression vector skeleton (vector skeleton: pCAMBIA2301 (available from CAMBIA mechanism)), carrying out recombination reaction on the HP1M nucleotide sequence connected with the universal joint primer 2 and the linearized DBNBC-02 expression vector skeleton, and constructing a recombinant expression vector DBN11770 according to the specification of an In-Fusion seamless connection product kit (Clontech, CA, USA, CAT: 121416) of Takara company, wherein the structure schematic diagram of the recombinant expression vector DBN11770 is shown In FIG. 5 (Spec: spectinomycin gene; RB right border, eFMV 34S enhancer of figwort mosaic virus (SEQ ID NO: 16), prBrCBP promoter of rape eukaryotic elongation factor gene 1 alpha (Tsf 1) (SEQ ID NO: 17), spAtCTP 2A Arabidopsis chloroplast transit peptide (SEQ ID NO: 18), EPSPS 5-enolpyruvshikimate-3-phosphate synthase gene (SEQ ID NO: 19), tPsE9 terminator of pea RbcS gene (SEQ ID NO: 20), prAtUbi10 promoter of Arabidopsis Ubiquitin (Ubiquinin) 10 gene (SEQ ID NO: 21), spAtCTP 2A Arabidopsis chloroplast transit peptide (SEQ ID NO: 18), HP1M nucleotide sequence (SEQ ID NO: 3), tNos A terminator of nopaline synthase gene (SEQ ID NO: 22), pr35S cauliflower mosaic virus 35S promoter (SEQ ID NO: 23), phosphinothricin N17) An acetyltransferase gene (SEQ ID NO: 24); t35S: the cauliflower mosaic virus 35S terminator (SEQ ID NO: 25); LB: left boundary).
The recombinant expression vector DBN11770 is used for transforming competent cells of the escherichia coli T 1 by a heat shock method, and the heat shock conditions are as follows: 50. Mu.L of E.coli T 1 competent cells, 10. Mu.L of plasmid DNA (recombinant expression vector DBN 11770), 42℃in a water bath for 30s; shake culturing at 37deg.C for 1 hr (shaking table at 100 rpm); then cultured on the LB solid plate (tryptone 10g/L, yeast extract 5g/L, naCl g/L, agar 15g/L, pH adjusted to 7.5 with NaOH) containing 50mg/L of spectinomycin (Spectinomycin) at 37℃for 12 hours, white colonies were picked up, and cultured in LB liquid medium (tryptone 10g/L, yeast extract 5g/L, naCl g/L, spectinomycin 50mg/L, pH adjusted to 7.5 with NaOH) at 37℃for overnight. Extracting the plasmid by an alkaline method: centrifuging the bacterial solution at 12000rpm for 1min, removing supernatant, and suspending the precipitated bacterial cells with 100 μl ice-precooled solution I (25 mM Tris-HCl, 10mM EDTA (ethylenediamine tetraacetic acid), 50mM glucose, pH 8.0); 200. Mu.L of freshly prepared solution II (0.2M NaOH, 1% SDS (sodium dodecyl sulfate)) was added, the tube was inverted 4 times, mixed, and placed on ice for 3-5min; adding 150 μl ice-cold solution III (3M potassium acetate, 5M acetic acid), immediately mixing, and standing on ice for 5-10min; centrifuging at 4deg.C and 12000rpm for 5min, adding 2 times volume of absolute ethanol into the supernatant, mixing, and standing at room temperature for 5min; centrifuging at 4deg.C and 12000rpm for 5min, removing supernatant, washing precipitate with 70% ethanol (V/V), and air drying; adding 30. Mu.L of TE (10 mM Tris-HCl, 1mM EDTA, pH 8.0) containing RNase (20. Mu.g/mL) to dissolve the precipitate; digesting RNA in a water bath at 37 ℃ for 30 min; preserving at-20deg.C for use. Sequencing and identifying the extracted plasmid, and the result shows that the nucleotide sequence of the recombinant expression vector DBN11770 between the Spe I and Asc I sites is the nucleotide sequence shown in SEQ ID NO. 3 in the sequence table, namely the HP1M nucleotide sequence.
According to the method for constructing the recombinant expression vector DBN11770, the HP1-1M nucleotide sequence and the HP1-2M nucleotide sequence which are respectively connected with the universal joint primer 2 are respectively subjected to recombination reaction with the linearized DBNBC-02 expression vector skeleton, so that the recombinant expression vectors DBN11777 and DBN11778 are sequentially obtained. Sequencing verifies that the nucleotide sequences in the recombinant expression vectors DBN11777 and DBN11778 respectively contain the nucleotide sequence shown in SEQ ID NO. 8 and the nucleotide sequence shown in SEQ ID NO. 11 in the sequence table, namely, the HP1-1M nucleotide sequence and the HP1-2M nucleotide sequence are correctly inserted.
According to the method for constructing the recombinant expression vector DBN11770, a control recombinant expression vector DBN11770N is constructed, the vector structure of which is shown in FIG. 6 (Spec: spectinomycin gene; RB: right border; eFMV: figwort mosaic virus 34S enhancer (SEQ ID NO: 16), prBrCBP: promoter of rape eukaryotic elongation factor gene 1α (Tsf 1) (SEQ ID NO: 17), spAtCTP2: arabidopsis chloroplast transit peptide (SEQ ID NO: 18), EPSPS: 5-enolpyruvylshikimate-3-phosphate synthase gene (SEQ ID NO: 19), tPsE9: terminator of pea RbcS gene (SEQ ID NO: 20), pr35S: cauliflower mosaic virus 35S promoter (SEQ ID NO: 23), PAT: phosphinothricin N-acetyl transferase gene (SEQ ID NO: 24), t35S: cauliflower mosaic virus 35S terminator (SEQ ID NO:25 LB) and left border.
2. Agrobacterium transformation of arabidopsis recombinant expression vector
The correctly constructed recombinant expression vectors DBN11770, DBN11777, DBN11778 and the control recombinant expression vector DBN11770N are respectively transformed into agrobacterium GV3101 by a liquid nitrogen method, and the transformation conditions are as follows: 100. Mu.L of Agrobacterium GV3101, 3. Mu.L of plasmid DNA (recombinant expression vector); placing in liquid nitrogen for 10min, and warm water bath at 37deg.C for 10min; the transformed agrobacterium GV3101 is inoculated in an LB test tube and cultured for 2 hours at the temperature of 28 ℃ and the rotating speed of 200rpm, and the agrobacterium is coated on an LB solid plate containing 50mg/L of Rifampicin (RIFAMPICIN) and 50mg/L of spectinomycin until positive monoclone grows, the monoclone is selected for culture and plasmid is extracted, and the extracted plasmid is subjected to sequencing identification, so that the result shows that the structures of the recombinant expression vectors DBN11770, DBN11777, DBN11778 and DBN11770N are completely correct.
3. Obtaining transgenic Arabidopsis plants
Wild-type Arabidopsis seeds were suspended in 0.1% (w/v) agarose solution. The suspended seeds were kept at 4 ℃ for 2 days to fulfill the need for dormancy to ensure synchronized germination of the seeds. The soil mixture was drained for 24 hours by mixing Ma Fentu with vermiculite and sub-irrigating with water until wet. The pretreated seeds were planted on the soil mixture and covered with a moisture-retaining cover for 7 days. Seeds were germinated and plants were grown in a greenhouse under long-day conditions (16 h light/8 h dark) with a constant temperature (22 ℃) and constant humidity (40-50%) and a light intensity of 120-150. Mu. Mol/m 2s-1. Plants were initially irrigated with Hoagland's nutrient solution followed by deionized water to keep the soil moist but not wet.
Arabidopsis thaliana was transformed using the floral dip method. One or more 15-30mL precultures of LB medium containing spectinomycin (50 mg/L) and rifampicin (10 mg/L) were inoculated with the selected Agrobacterium colonies. The preculture was incubated overnight at a constant shaking speed at a temperature of 28℃at 220 rpm. Each preculture was used to inoculate two 500ml cultures of the YEP broth containing spectinomycin (50 mg/L) and rifampicin (10 mg/L) and the cultures were incubated at 28℃with continuous shaking overnight. The cells were pelleted by centrifugation at about 4000rpm for 20min at room temperature and the resulting supernatant was discarded. The cell pellet was gently resuspended in 500mL of an osmotic medium containing 1/2 XMS salt/B5 vitamin, 10% (w/v) sucrose, 0.044. Mu.M benzylaminopurine (10. Mu.L/L (stock solution in 1mg/mL DMSO)) and 300. Mu.L/LSilvet L-77. Arabidopsis plants of about 1 month of age were soaked in the permeate medium containing the resuspended cells for 5min, ensuring that the latest inflorescences were submerged. Then the sides of the Arabidopsis plants are laid down and covered, after the Arabidopsis plants are moisturized for 24 hours in a dark environment, the Arabidopsis plants are normally cultivated at the temperature of 22 ℃ with the photoperiod of 16h light/8 h darkness. Seeds were harvested after about 4 weeks.
The newly harvested (HP 1M nucleotide sequence, HP1-2M nucleotide sequence, and control vector DBN 11770N) T 1 seeds were dried at room temperature for 7 days. Seeds were planted in 26.5cm x 51cm germination trays, each tray receiving 200mg of T 1 seeds (about 10000 seeds) which had been previously suspended in distilled water and stored at a temperature of 4 ℃ for 2 days to fulfill the need for dormancy to ensure synchronized germination of the seeds.
Mixing Ma Fentu with vermiculite and irrigating with water bottom until wet, draining with gravity. The pretreated seeds were planted uniformly on the soil mixture with a pipette and covered with a moisturizing cap for 4-5 days. The cover was removed 1 day prior to the initial transformant selection using post-emergence spray of glufosinate (co-transformed PAT gene selection). After 7 days of planting (DAP) and again using a DeVilbiss compressed air nozzle at 11DAP, T 1 plants (cotyledonary and 2-4 foliar stages, respectively) were sprayed with a 0.2% solution of Liberty herbicide (200 g ai/L glufosinate) at a spray volume of 10 mL/tray (703L/ha) to provide an effective amount of glufosinate per application of 280g ai/ha. Surviving plants (actively growing plants) were identified 4-7 days after the final spraying and transplanted into 7cm x 7cm square pots (3-5 plants per tray) prepared with struvite and vermiculite, respectively. The transplanted plants were covered with a moisture-retaining cover for 3-4 days and placed in a culture chamber at a temperature of 22℃as before or directly transferred into a greenhouse. The cover was then removed and the plants were planted in the greenhouse (22.+ -. 5 ℃ C., 50.+ -. 30% RH,14h light: 10h darkness, minimum 500. Mu.E/M 2s-1 natural+ supplemental light) at least 1 day before testing the ability of the HP1M gene, HP1-1M gene and HP1-2M gene to provide topramezone herbicide tolerance.
4. Herbicide tolerance effect detection of transgenic arabidopsis plants
The T 1 transformants were first selected from the untransformed seed background using the glufosinate selection protocol. The transgenic recombinant expression vector DBN11770 is an Arabidopsis plant (HP 1) with the HP1M nucleotide sequence, the transgenic recombinant expression vector DBN11777 is an Arabidopsis plant (HP 1-1) with the HP1-1M nucleotide sequence, the transgenic recombinant expression vector DBN11778 is an Arabidopsis plant (HP 1-2) with the HP1-2M nucleotide sequence, and the transgenic recombinant expression vector DBN11770N is an Arabidopsis plant (control vector) with the control recombinant expression vector. About 20000T 1 seeds of HP1 were screened and 213T 1 generation positive transformants (PAT gene) were identified, about 1.0% conversion efficiency; about 20000T 1 seeds of HP1-1 were screened, and 195T 1 generation positive transformants (PAT gene) were identified, about 1.0% conversion efficiency; about 20000T 1 seeds of HP1-2 were screened, and 195T 1 generation positive transformants (PAT gene) were identified, about 1.0% conversion efficiency; t 1 seeds of about 20000 control vectors were screened, and 172T 1 generation positive transformants (PAT gene) were identified with a transformation efficiency of about 0.86%.
The HP1 Arabidopsis T 1 plants, HP1-1 Arabidopsis T 1 plants, HP1-2 Arabidopsis T 1 plants, arabidopsis T 1 plants of the control vector and wild type Arabidopsis plants (CK) (18 days after sowing) were sprayed with 3 concentrations of topramen, respectively, to examine herbicide tolerance of Arabidopsis, namely 25gai/ha (1-fold field concentration, 1×), 100g ai/ha (4-fold field concentration, 4×) and 0g ai/ha (water, 0×). After 7 days of spraying (7 DAT), the extent of injury to each plant by the herbicide was counted according to the leaf whitening area ratio (leaf whitening area ratio = leaf whitening area/total leaf area x 100%). The substantially non-whitening phenotype was rated 0, the proportion of leaf whitening area was rated 1, the proportion of leaf whitening area was rated more than 50% was rated 2, and the proportion of leaf whitening area was rated 100% was rated 3. Transformation event resistance performance of each recombinant expression vector was scored according to the formula x= [ Σ (n×s)/(t×m) ]×100. (X-phytotoxicity score, N-peer victim number, S-phytotoxicity grade number, T-total plant number, M-highest phytotoxicity grade), and resistance evaluation was performed according to the score: high resistant plants (0-15 min), medium resistant plants (16-33 min), low resistant plants (34-67 min), and non-resistant plants (68-100 min). The experimental results are shown in table 2.
TABLE 2 results of experiments on the tolerance of transgenic Arabidopsis T 1 plants to topramezone
The results in table 2 show that: compared with an arabidopsis T 1 plant and a wild arabidopsis plant which are transferred into a control vector DBN11770N, the arabidopsis T 1 plant transferred into an HP1M nucleotide sequence, the arabidopsis T 1 plant transferred into an HP1-1M nucleotide sequence and the arabidopsis T 1 plant transferred into an HP1-2M nucleotide sequence can generate tolerance to topramezone to different degrees; compared with an Arabidopsis T 1 plant with the HP1M nucleotide sequence, an Arabidopsis T 1 plant with the HP1-1M nucleotide sequence and an Arabidopsis T 1 plant with the HP1-2M nucleotide sequence have better resistance to topramezone.
In summary, the amino acid sequence 159 of the herbicide tolerance protein HP1 of the invention is mutated from threonine to alanine or 258 from glutamine to methionine (the herbicide tolerance protein HP1-1 or HP 1-2) can show higher tolerance to HPPD inhibitor herbicide, and the herbicide tolerance protein can tolerate topramezone (middle resistance) with 1-time field concentration, so the application prospect on plants is wide.
Finally, it should be noted that the above-mentioned embodiments are merely for illustrating the technical solution of the present invention and not for limiting the same, and although the present invention has been described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications and equivalents may be made to the technical solution of the present invention without departing from the spirit and scope of the technical solution of the present invention.
Claims (14)
1. A protein characterized by having an amino acid sequence shown in SEQ ID NO. 9.
2. A gene, comprising:
(a) A nucleotide sequence encoding the protein of claim 1; or (b)
(B) The nucleotide sequence shown as SEQ ID NO. 10 or SEQ ID NO. 11.
3. An expression cassette comprising the gene of claim 2 under the control of operably linked regulatory sequences.
4. A recombinant vector comprising the gene of claim 2 or the expression cassette of claim 3.
5.A method of extending the range of herbicides tolerated by plants comprising: the protein of claim 1 or the protein encoded by the expression cassette of claim 3 is expressed in a plant with at least one second herbicide tolerance protein different from the protein of claim 1 or the protein encoded by the expression cassette of claim 3, the second herbicide tolerance protein being 5-enolpyruvylshikimate-3-phosphate synthase, glyphosate oxidoreductase, glyphosate-N-acetyltransferase, glyphosate decarboxylase, glufosinate acetyltransferase, alpha ketoglutarate-dependent dioxygenase, dicamba monooxygenase, acetolactate synthase, cytochrome-like protein and/or protoporphyrinogen oxidase, the plant being oat, wheat, barley, millet, corn, sorghum, brachypodium distachyon, rice, tobacco, sunflower, alfalfa, soybean, chickpea, peanut, beet, cucumber, cotton, potato, tomato or arabidopsis thaliana.
6. A method of selecting a transformed plant cell comprising: transforming a plurality of plant cells with the gene of claim 2 or the expression cassette of claim 3 and culturing the cells at a concentration of an HPPD inhibitor herbicide that kills or inhibits the growth of untransformed cells, said HPPD inhibitor herbicide being topramezone, mesotrione and/or diketo nitrile, said plant being oat, wheat, barley, millet, corn, sorghum, brachypodium distachyon, rice, tobacco, sunflower, alfalfa, soybean, chickpea, peanut, beet, cucumber, cotton, canola, potato, tomato or arabidopsis thaliana.
7. A method of controlling weeds, comprising: applying an effective dose of an HPPD inhibitor herbicide to a field in which a plant of interest is grown, said plant of interest comprising the gene of claim 2 or the expression cassette of claim 3 or the recombinant vector of claim 4, said HPPD inhibitor herbicide being topramezone, mesotrione and/or diketo nitrile, said plant of interest being oat, wheat, barley, millet, corn, sorghum, brachypodium distachyranthes, rice, tobacco, sunflower, alfalfa, soybean, chickpea, peanut, beet, cucumber, cotton, canola, potato, tomato or arabidopsis thaliana.
8. The method of controlling weeds of claim 7, wherein said plant of interest is a glyphosate tolerant plant and said weeds are glyphosate tolerant weeds.
9. A method for protecting a plant from injury caused by or conferring HPPD inhibitor herbicide tolerance to a plant, comprising: introducing the gene of claim 2 or the expression cassette of claim 3 or the recombinant vector of claim 4 into a plant, wherein the introduced plant produces an amount of herbicide tolerance protein sufficient to protect the plant from the HPPD inhibitor herbicide selected from the group consisting of topramezone, mesotrione and/or diketo nitrile, and wherein the plant is oat, wheat, barley, millet, corn, sorghum, brachypodium distachyranthes, rice, tobacco, sunflower, alfalfa, soybean, chickpea, peanut, beet, cucumber, cotton, canola, potato, tomato, or arabidopsis thaliana.
10. A method of producing a plant resistant to an HPPD inhibitor herbicide, comprising introducing into the genome of a plant the gene of claim 2, wherein the HPPD inhibitor herbicide is topramezone, mesotrione, and/or diketo nitrile, and the plant is oat, wheat, barley, millet, corn, sorghum, brachypodium distachyon, rice, tobacco, sunflower, alfalfa, soybean, chickpea, peanut, beet, cucumber, cotton, canola, potato, tomato, or arabidopsis thaliana.
11. The method of producing a HPPD inhibitor herbicide tolerant plant according to claim 10, wherein the method of introduction comprises a genetic transformation method, a genome editing method or a gene mutation method.
12. A method of growing a plant tolerant to an HPPD inhibitor herbicide, comprising:
Growing at least one plant propagule comprising in its genome the gene of claim 2 or the expression cassette of claim 3;
growing the plant propagules into plants;
Applying an effective dose of an HPPD inhibitor herbicide, which is topramezone, mesotrione and/or diketo nitrile, to a plant growth environment comprising at least said plant, said plant being oat, wheat, barley, millet, corn, sorghum, brachypodium distachyon, rice, tobacco, sunflower, alfalfa, soybean, chickpea, peanut, beet, cucumber, cotton, canola, potato, tomato or arabidopsis thaliana, to a plant growth environment comprising at least said plant, and harvesting a plant having reduced plant damage and/or increased plant yield as compared to other plants not having the gene of claim 2 or the expression cassette of claim 3.
13. A method of obtaining a processed agricultural product comprising treating a harvest of HPPD inhibitor herbicide tolerant plants obtained by the method of claim 12 to obtain a processed agricultural product.
14. Use of a protein according to claim 1 for conferring tolerance to HPPD inhibitor herbicides which are topramezone, mesotrione and/or diketene nitrile in plants which are oat, wheat, barley, millet, corn, sorghum, brachypodium distachyranthes, rice, tobacco, sunflower, alfalfa, soybean, chickpea, peanut, beet, cucumber, cotton, canola, potato, tomato or arabidopsis thaliana.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210330228.1A CN114854702B (en) | 2020-03-19 | 2020-03-19 | Herbicide tolerance protein, coding gene and application thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210330228.1A CN114854702B (en) | 2020-03-19 | 2020-03-19 | Herbicide tolerance protein, coding gene and application thereof |
CN202010194585.0A CN111304178B (en) | 2020-03-19 | 2020-03-19 | Herbicide tolerance protein, coding gene and application thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010194585.0A Division CN111304178B (en) | 2020-03-19 | 2020-03-19 | Herbicide tolerance protein, coding gene and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114854702A CN114854702A (en) | 2022-08-05 |
CN114854702B true CN114854702B (en) | 2024-04-19 |
Family
ID=71157254
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210330228.1A Active CN114854702B (en) | 2020-03-19 | 2020-03-19 | Herbicide tolerance protein, coding gene and application thereof |
CN202010194585.0A Active CN111304178B (en) | 2020-03-19 | 2020-03-19 | Herbicide tolerance protein, coding gene and application thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010194585.0A Active CN111304178B (en) | 2020-03-19 | 2020-03-19 | Herbicide tolerance protein, coding gene and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN114854702B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117778338A (en) * | 2021-03-24 | 2024-03-29 | 华中师范大学 | HPPD proteins, genes, vectors, cells, compositions, uses thereof and methods for increasing herbicide resistance in crops |
CN113980990B (en) * | 2021-11-26 | 2022-07-26 | 中国农业科学院生物技术研究所 | Transgenic insect-resistant herbicide-resistant corn and cultivation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110628733A (en) * | 2019-09-17 | 2019-12-31 | 北京大北农生物技术有限公司 | Herbicide tolerance protein, coding gene and application thereof |
CN110656094A (en) * | 2019-09-17 | 2020-01-07 | 北京大北农生物技术有限公司 | Herbicide tolerance protein, coding gene and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110628732B (en) * | 2019-09-17 | 2022-04-15 | 北京大北农生物技术有限公司 | Herbicide tolerance protein, coding gene and application thereof |
-
2020
- 2020-03-19 CN CN202210330228.1A patent/CN114854702B/en active Active
- 2020-03-19 CN CN202010194585.0A patent/CN111304178B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110628733A (en) * | 2019-09-17 | 2019-12-31 | 北京大北农生物技术有限公司 | Herbicide tolerance protein, coding gene and application thereof |
CN110656094A (en) * | 2019-09-17 | 2020-01-07 | 北京大北农生物技术有限公司 | Herbicide tolerance protein, coding gene and application thereof |
Non-Patent Citations (1)
Title |
---|
"Physiological and Molecular Characterization of Hydroxyphenylpyruvate Dioxygenase (HPPD)-inhibitor Resistance in Palmer Amaranth (Amaranthus palmeri S.Wats.)";Sridevi Nakka等;《Frontiers in Plant Science》;第8卷;摘要,第2页左栏第2段,右栏第2段,第5页右栏结果部分第1段,尤其是最后3行,第7-8页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111304178B (en) | 2022-06-03 |
CN111304178A (en) | 2020-06-19 |
CN114854702A (en) | 2022-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2016399292B2 (en) | Herbicide tolerant protein, encoding gene and use thereof | |
CA2975762C (en) | Herbicide-resistant protein, encoding gene and use thereof | |
WO2021051265A1 (en) | Mutant hydroxyphenylpyruvate dioxygenase polypeptide, encoding gene thereof and use thereof | |
US20210324404A1 (en) | Herbicide tolerance protein, encoding gene thereof and use thereof | |
CN110628733B (en) | Herbicide tolerance protein, coding gene and application thereof | |
CA2975773C (en) | Herbicide-resistant protein, encoding gene and use thereof | |
CN114854702B (en) | Herbicide tolerance protein, coding gene and application thereof | |
CA2976060C (en) | Herbicide-resistant protein, encoding gene and use thereof | |
CN111334484B (en) | Herbicide tolerance protein, coding gene and application thereof | |
CN110656094B (en) | Herbicide tolerance protein, coding gene and application thereof | |
CN110628732B (en) | Herbicide tolerance protein, coding gene and application thereof | |
CN115340987B (en) | Herbicide tolerance protein, coding gene and application thereof | |
WO2023108495A1 (en) | Mutated hydroxyphenylpyruvate dioxygenase polypeptide, and coding gene and use thereof | |
WO2022237541A1 (en) | Use of protoporphyrinogen oxidase | |
WO2023206126A1 (en) | Use of protoporphyrinogen oxidase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant |